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CHAPTER-1 
INTRODUCTION 
Herbal drugs have been used as medicines for the treatment of various ailments since 
time immemorial and hence plants always have an ever green role in the health care system. 
Each and every plant is similar to a factory which has a ability to synthesize a sizable amount 
of unusual phytoconstituents which are highly complex in structures [1]. 
Plants are the only economic source of a member of well-established and important 
drugs. In spite of tremendous advances made in the modern system of medicine, there are still 
certain disease conditions for which suitable drugs are not available in the Allopathic system. 
Moreover, the modern system of medicine produces lot of side effects to the patients [2]. 
Nowadays herbs have been the main source of medicine throughout the human history. About 
25 to 30% of today’s prescription drugs contains chemical derived from herbs [3].  
The factors responsible for the continued and extensive use of herbal drugs in India 
are their effectiveness, easy availability, low cost, comparatively less toxic effects and 
storage. 
Herbal drugs are having complex molecular architecture and they show amazing 
arrangements of functional group, ring system and other structural attributes. The reasons for 
interest in herbal drugs are [4] 
 Serve as a lead compounds for newer drugs 
 Give information about the bio mechanism  
 Natural products are permanent challenge with respect to synthesis and 
stimulate the development of new reagents and reactions. 
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 Collection of natural products as well as their derivatives and analogues 
are valuable starting points for drug discovery [5] 
The main limitation of the plant is the lack of standardization of raw materials, 
processing methods, the final products, dosage, formulations and non-existence criteria for 
quality control. 
The plant kingdom still hold many species of plants containing substance of medicinal 
value which have yet to be discovered and large numbers of plants are constantly being 
screened for their pharmacological value. So that we have to make an attempt to identify the 
medicinal herbs used for mankind. 
Urolithiasis 
 Nephrolithiasis term indicates that the disease is characterized by the formation of 
stone in the kidneys or urinary tract. Kidney stone, also known as  renal calculus (from the 
Latin rēnēs, "kidneys," and calculus, “pebble”), is a solid concretion or crystal aggregation 
formed in the kidneys from dietary minerals in the urine.[6] 
Epidemiology 
 Nearly 4-15% of the human populations are suffering from urinary stone problem in 
all over the globe. 13% of men and 75% of women will develop kidney stone during their life 
time in the US. The area of high incidence of urinary calculi are British islands, Scandinvian 
countries, Central Europe, Northern Australia, Northern India, Pakistan, Mediterranean 
countries. So they are known as Stone belts. 
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Mode of formation 
Excretion of stone substances (eg: oxalate) + Calcium 
Supersaturated solution of salt  
Bacteria (eg: nano bacteria)                                Lack of substances keeping calcium salts 
Solution  
                                                                              (Magnesium, phosphate) 
                                                                               Lack of inhibitors of crystal formation 
                                                                               Citrate, inorganic pyrophosphate & few 
                                                                               Uroepithelial glycoproteins 
Inhibiting nidus of calcium 
 
     Precipitation and salt formation   
 
Pre disposing factors 
Urinary pH 
Dehydration- causes increased urinary concentration. 
Stasis- obstruction to urine flow encourages salt precipitation 
Renal disease 
Metabolic factors- Hyper calcuria, hyper phosphaturia, oxaluria, urate excess 
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EFFECT & COMPLICATION: 
Passage of small size stone                        Colic 
 
Injury to ureter 
  
Stricture 
        
Subsequent impaction of stone 
Passage of larger stone               Impaction at upper & lower ends of ureter 
      or at brim of pelvi 
        
Stasis  
 
    Hydronephrosis  Infection 
 
     
       Staghorn calculus (Suppuration & 
       ulceration of pelvis & calculus leads to 
       squamous metaplasia) 
Types:[106] 
1. Calcium stones: 
Calcium oxalate (50%), Calcium phosphate (50%), mixture of calcium oxalate & 
calcium phosphate (45%) 
2. Mixed (struvite) stones 
Magnesium-ammonium-calcium phosphate 
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3. Uric acid stone (5-10%) 
4. Cystine stones (1%) 
    Hereditary xanthinuria, xanthine stones. 
Treatment [7] 
 Calcium stones are treated with Thiazide diuretics & allopurinol. 
 Antimicrobial agents, judicious surgery are used for the treatment of struvite 
stones. 
 Alkali & allopurinol are useful in uric acid stones. 
 Cystine stones are treated with allopurinol & penicillamine 
Herbal drugs used for the treatment of Urolithiasis 
 The plants which find use in the treatment of urolithiasis are Coleus aromaticus 
(Labiatae), Cucurbita pepo (Cucurbitaceae), Mallotus philippensis (Euphorbiaceae), Tribulus 
terrestris (Zygophyllaceae) and Bergenia ligulata (Saxifragaceae). 
Diabetes mellitus[8] 
Diabetes mellitus is a metabolic disease characterized by dysregulation of 
carbohydrate, protein, and lipid metabolism. The primary feature of this disorder is elevation 
in blood glucose levels (hyperglycemia), resulting from either a defect in insulin secretion 
from the pancreas, a change in insulin action or both. Sustained hyperglycemia has been 
shown to affect almost all tissues in the body and is associated with significant complications 
of multiple organ systems, including the eyes, nerves, kidneys and blood vessels.  
These complications are responsible for the high degree of morbidity and mortality 
seen in the diabetic population. 
Epidemiology 
About 16 million Americans have diabetes (between 6 and 7% of the total US 
population). Around the world, the prevalence of diabetes is expected to double between 
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1994 and 2010, at which time about 240 million people will have the disease. In the United 
States, the incidence of diabetes rises as the population ages and as the prevalence of obesity 
increases. There are 60 to 70 diabetic individuals for every 1,000 patients and 30 to 35 of 
these patients are undiagnosed.  
Classification 
1. Type 1 diabetes was previously called insulin-dependent diabetes or juvenile diabetes.  
results from beta cell destruction, leading to absolute insulin deficiency. 
2. Type 2 diabetes was formerly known as non-insulin-dependent diabetes or adult-onset 
diabetes resulting from a progressive insulin secretion defect on a background of impaired 
insulin function 
3. Gestational diabetes occurs during pregnancy and usually resolves after delivery. Other 
types of diabetes may occur in individuals with certain genetic disorders, pancreatic diseases, 
infections, injuries to the pancreas and endocrine diseases. Drug therapy with certain agents 
may also induce a diabetic state. 
Symptoms of diabetes 
The symptoms include intense thirst, polyphagia, polyuria (frequent                        
urination with increased amount of urine), acute hyperglycemic crisis: diabetic ketoacidosis 
(DKA) and hyperglycemica, hyperosmolar coma (HHS), blurred vision (osmotic swelling of 
lenses), dizziness, extreme tiredness, genital itching, nausea, vomiting, slow healing of 
wounds 
Treatment 
The major components of the treatment of diabetes are: 
1. Diet (combined with exercise if possible). 
2. Oral hypoglycaemic therapy. 
3. Insulin treatment. 
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Herbal drug used in the treatment of Diabetes mellitus 
Some of the plants used in the treatment of Diabetes include Andrographis paniculata 
(Acanthaceae), Ficus benghalensis (Moraceae), Ficus glomerata (Moraceae), Psidium 
guajava (Myrtaceae), Syzygium cumini (Myrtaceae), Posidonia oceanic (Posidoniaceae), 
Bruguiera gymnorrhiza (Rhizophoraceae), Aegle marmelos (Rutaceae), Salvadora oleoides 
(Salvadoraceae), Phyllanthus reticulates (Phyllanthaceae) and Selaginella tamariscina 
(Selaginellaceae) 
Infectious diseases [9] 
Infectious diseases are caused by microorganisms such as bacteria, viruses, fungi or 
parasites. Some of these organisms constitute the “normal flora” or micro biota present and 
are participating in the metabolism of food products, the protection against pathogenic 
microorganisms and the development and stimulation of the immune system. However, some 
of them can become pathogenic, for instance when introduced in normally sterile 
environments such as the blood or in case of suppression of the immune system. Besides 
these opportunistic pathogens (e.g., Staphylococcus aureus, Escherichia coli, Candida 
albicans)strict pathogens exist that do not belong to the normal flora and can cause disease 
(e.g., Mycobacterium tuberculosis, Vibrio cholera, Neisseria gonorrhoeae). Clinical 
symptoms associated with infectious diseases are mostly not disease-specific or not 
microorganism-specific and often include general signs such as fever, loss of appetite, fatigue 
and muscle aches. Therefore, laboratory tests of different body fluid samples (e.g., blood, 
urine, cerebrospinal fluid (CSF)) are used for the detection and determination of the causative 
agent. Traditional culture-based methods in the clinical microbiology laboratory are time-
consuming and are associated with a low sensitivity in case of slow-growing or fastidious 
microorganisms. 
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An infection is the colonization of a host organism by parasite species. Infecting 
parasites seek to use the host’s resources to reproduce, often resulting in disease. Colloquially 
infections are usually considered to be caused by microorganism or micro parasites like 
viruses, bacteria, viroids, though larger organism like macro parasites and fungi can also 
infect.  
Hosts normally fight infections themselves via their immune system. Mammalian 
hosts react to infections with an innate response, often involving inflammations followed by 
an adaptive response. Pharmaceuticals can also help to fight infections.  
Infections may be divided into following 
 Bacterial infections 
 Fungal infections 
 Parasitic infections 
 Protozoan infections 
 Viral infections 
 Worms infestation 
Bacterial infections 
Pathogenic bacteria are bacteria which causes bacterial infections. Although the vast 
majority of bacteria are harmless or beneficial, quite a few bacteria are pathogenic. The 
highly pathogenic bacteria are classified in to two types “gram positive bacteria” and “gram 
negative bacteria”. The pathogenic bacteria contribute to globally important diseases such as 
pneumonia, which are caused by bacteria such as Streptococcus and Pseudomonas and food 
borne illness such as tetanus, typhoid fever, diphtheria, syphilis, and leprosy. [10] 
Some of the bacteria that are highly pathogenic include Staphylococcus aureus 
Basillus substilis, Streptococcus viridians  S. pyogens (Gram positive bacteria)  Esherichia 
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coli, Klebsiella pneumonia, Proteus albus, Salmonella typhi,  Proteus mirabilis and  
Pseudomonas aeruginosa (Gram negative bacteria). 
Staphylococcus aureus can cause a range of illness ranging from minor skin infections 
such as pimples, boils, cellulitis, and folliculitis, scaled skin syndrome to life threatening 
diseases such as pneumonia, meninigitis, endocarditis, osteomyelitis, toxic shock syndrome, 
bacterimia and sepsis. It affects the skin, soft tissue, respiratory tract, bones, joints etc. It is 
one of the five most common causes of nosocomial infections and is often the cause of 
postsurgical wound infections. 
Pseudomonas aeruginosa is another common bacterium that can cause disease in 
animals, including humans. It is found in soil, water, skin flora, and most man-made 
environments throughout the world and thrives not only in normal atmospheres but also 
in hypoxic atmospheres and hence has colonized many natural and artificial environments. 
The organism generally infects damaged tissues or those with reduced immunity. The 
symptoms of infections are generalized inflammation and sepsis. If such colonization occurs 
in critical body organs, such as the lungs, urinary tract and kidneys, the results can be fatal. 
Because it thrives on most surfaces, this bacterium is also found on and in medical 
equipment including catheters, causing cross infections in hospitals and clinics. It also 
causes hot-tub rash. It is also able to decompose hydrocarbons and has been used to break 
down tar balls and oil from oil spills.[11] 
Fungal infections 
Pathogenic fungi are those that cause disease in humans or other organisms. The study 
of pathogenic fungi is referred to as medical mycology. Although fungi 
are eukaryotic organisms many pathogenic fungi are also microorganisms. A mycosis is 
a fungal infection of animals, including humans. Mycoses are common and a variety of 
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environmental and physiological conditions can contribute to the development of fungal 
diseases. Inhalation of fungal spores or localized colonization of the skin may initiate 
persistent infections; therefore, mycoses often start in the lungs or on the skin. 
People are at risk of fungal infections when they are taking strong antibiotics for a 
long period of time because antibiotics kill not only damaging bacteria, but healthy bacteria 
as well. This alters the balance of microorganisms in the mouth, vagina, intestines and other 
places in the body and results in an overgrowth of fungus. Individuals with weakened 
immune system are also at risk of developing fungal infections. This is the case of people 
with HIV/AIDS, people under steroid treatments and people taking chemotherapy. People 
with diabetes also tend to develop fungal infections. Very young and very old people also, are 
groups at risk. 
Mycoses are classified according to the tissue levels initially colonized 
 Superficial mycoses 
 Cutaneous mycoses 
 Subcutaneous mycoses 
 Systemic mycoses due to primary pathogens 
 Systemic mycoses due to opportunistic pathogens 
Candida species are important human pathogens that are best known for causing 
opportunist infections in immune compromised hosts (e.g. transplant patients, AIDS sufferers 
and cancer patients). 
The most common pathogenic fungi include Aspergillus fumigates and Aspergillus 
flavus. Aspergillus flavus produces aflatoxin, a toxin and a carcinogen and which can 
potentially contaminate foods such as nuts etc. Aspergillus fumigatus and Aspergillus 
clavatus can cause allergic diseases. Aspergillosis  is the group of diseases caused 
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by Aspergillus. The symptoms include fever, cough, chest pain or breathlessness. Usually, 
only patients with weakened immune systems or with other lung conditions are susceptible. 
 Cryptococcus neoformans  is another major human and animal pathogen. 
Cryptococcus laurentii and Cryptococcus albidus have been known to occasionally cause 
moderate to severe disease in human patients with compromised immunity. 
Viral Infections 
Viruses are tiny organisms that are made up of the genetic material known as DNA or 
RNA which the virus uses to replicate. It invades and attaches itself to a living cell in order to 
survive and then multiply and produce more virus particles. Viruses can be transmitted in 
numerous ways, such as through contact with an infected person, swallowing, inhalation, or 
unsafe sex. Poor hygiene and eating habits increases the risk of contracting a viral infection. 
Types of Viral Infections 
Viruses affect any part of the body and cause infections such as the common cold, flu, 
gastroenteritis, chicken pox or herpes. The most common type of viral infections involves the 
respiratory tract. 
The common cold is a frequently occurring viral infection and symptoms are 
sneezing, stuffy nose, sore throat and coughing. A cold can last from two days to two weeks 
though it is a minor infection of the nose and throat. They are highly contagious and are 
spread by fluids from sneezing or coughing, which contain the infection. 
Influenza, also known as the "flu", is a respiratory infection that is caused by viruses. 
The flu differs in several ways from the common cold. Symptoms of the flu include body 
chills, fever, headache, muscle ache and sore throat. Unlike many other viral respiratory 
infections, the flu can cause severe illness and life-threatening complications in many people. 
The flu is contracted in the same airborne manner as the common cold. The viruses are easily 
transmitted especially in highly populated areas. 
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Herpes is caused by the herpes simplex virus (HSV). This infection can infect the 
mouth, genitals and anus. Oral herpes causes sores around the mouth and face, while genital 
herpes affects the genitals, buttocks and anus. Genital herpes is known as a sexually 
transmitted disease (STD) and it is transmitted through sexual contact through the mouth and 
genitals. This virus can be spread even when sores are not present. Like chicken pox, this 
virus will remain in the body forever. The symptoms include fever, muscle aches, coughing, 
sneezing, runny nose, headache, chills, diarrhoea, vomiting, rashes and weakness. More 
severe symptoms include personality changes, neck stiffness, dehydration, seizures, paralysis 
of the limbs, confusion, back pain,  loss of sensation, impaired bladder and bowel function, 
sleepiness that can progress into a coma or death. 
Protozoan infections 
Protozoan infections are parasitic diseases caused by organisms, formerly classified in 
the Kingdom Protozoa. They include organisms classified in  Amoebozoa, Excavata and 
Chromalyeolata The species traditionally collectively termed "protozoa" are not closely 
related to each other and have only superficial similarities (eukaryotic, unicellular, motile, 
though with exceptions.) The term "protozoa" is discouraged in the modern biosciences but is 
still encountered in medicine. This is partially because of the conservative character of 
medical classification and partially due to the necessity of making identifications of 
organisms based upon appearances and not upon DNA. Examples include Entamoeba 
histolytica, Plasmodium (some of which cause malaria), and Giardia lamblia, Trypanosome 
brucei transmitted by the fly and the cause of African sleeping sickness. 
Tropical diseases 
Tropical diseases are infectious diseases that either occurs uniquely in tropical and 
subtropical regions (which is rare) or more commonly, either more widespread in the tropics 
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or more difficult to prevent or control. Since the advent of air travel, people more frequently 
visit these regions and contract many of these diseases, most notably malaria and hepatitis. 
Andrographis echioides is a very commonly seen herb and since vast work has been 
carried out on Andrographis paniculata and other species, an attempt has been made in this 
study to scientifically screen the herb for possible pharmacological activity. 
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CHAPTER-2 
REVIEW OF LITERATURE 
 
This chapter deals with a detailed review of the literature from secondary and tertiary 
sources on the pharmacognosy, phytochemistry and pharmacology of the various species of 
Andrographis. This chapter helps us to find out the various activities and chemicals isolated 
from various species of Andrographis. 
Andrographis echioides 
Jayaprakasam B et al., (2001) have studied the isolation of new chalcone glucoside, 
androechin from Andrographis echioides. The flavone glucoside, echioidinin 5-O-glucoside 
were isolated from ethyl acetate extract.  The Androechin was characterized as 2, 2’, 6’-
trihydroxy-4’-methoxy chalcone, 2’-O-β-D-glucopyranoside by spectral and chemical 
studies. [12] 
Qadrie ZL et al., (2009) have evaluated antibacterial activity of ethanolic extract of 
Indoneesiella echioides (L.) Nees, by the filter paper disc method against Staphylococcus 
aureus and E. coli bacteria. The organisms maintained on nutrient agar slants were using 
nutrient broth. One loop full of the respective culture was taken in slants and maintained 
below 40°C and incubated at 37°C for 24h which were observed for the growth of organism 
and compared with that of sterile broth. The presence of turbidity indicates growth and 
suitability of the culture.[13] 
Radha R et al., (2011) have studied the phytochemical screening and antimicrobial 
activity of various extracts of Andrographis echioides (L.) Nees. The petroleum ether, 
chloroform, acetone, methanol extracts of leaves and stem of Andrographis  echioides against 
Gram +ve, two gram (-) bacteria and two fungi using disc diffusion method. The 
phytochemical screening results revealed the presence of alkaloids, flavonoids, glycosides, 
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phenols, tannins and saponins in leaf and stem. The highest activity was observed against 
Gram (+) bacteria in leaf and stem extract. The anti -fungal activity against Candida albicans 
was observed. [14] 
OTHER SPECIES 
Andrographis paniculata 
Viswanathan et al., (1981) have isolated the flavone, apigenin 7, 4’-dio –o-methyl 
ether from Andrographis paniculata ,which  showed significant antiulcer activity in Shay 
rats,histamine induced ulcer in guinea pig and aspirin ulcers in rats.[15] 
 Huc Q and Zhou BN (1982) have isolated the two diterpenoid glycoside from 
Andrographis paniculata.  Two new glucosides are 14-deoxy andrographolide-19-β glucoside 
and andrographolide-19β glucoside.[16] 
Dutta A and Sukul NC (1982) have studied the filaricidal properties of 
Andrographis paniculata. The water decoction of these leaves killed the microfilaria of 
dipetalonema within 40min by in vitro method.[17] 
Zhang CY (1996) has studied cardiovascular activity of aqueous extract of 
Andrographis paniculata in anesthetized rats. The extract significantly produce decreased 
blood pressure and heart rate and exhibited anti-hypertensive effect in chronic and acute 
hypertensive rats.[18] 
Burgos RA et al., (1997) have evaluated the testicular toxicity of dried extract of 
Andrographis paniculata in male Sprague rats at dose level 20, 200, 1000µg/kg daily for 60 
days and observed the reproductive organ weight and testicular histology and ultra-structural 
analysis and testosterone level.  The Andrographis paniculata extract did not produce 
subchronic testicular toxicity effect in male rats.[19] 
Gupta PP (1998) has evaluated the anti-allergic activity of diterpene andrographolide 
and neo andrographolide from Andrographis paniculata, these were tested Anti-PCA 
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(passive cutaneous anaphylaxis) and mast cell stability activity in rats. These isolates 
possessed mast cell stability activity against compound 48/80 and sensitized mast cells, 
against egg albumin induced egg albumin.This activity was comparable to disodium 
chromoglycate.[20] 
Date S et al.,(1999) have reported the hepatoprotective activity of various plants. 
Phyllanthus species, Picrrorhiza kurroa, G.glabra, Andrographis paniculata, Eu 
microphylla, Tridax procumbens, Coccinia indica, Cassia fistula are used as 
hepatoprotective plants.[21] 
Zafar R and Mehta P (1999) have reported andrographolide in root culture of 
Andrographis paniculata Nees. The static culture contained MS medium supplemented with 
BA and 2,4D for the production andrographolide and the andrographolide in root callus 
extract was found to be 0.04mg% and plant root extract 0.29mg %.[22] 
Amrogan E et al., (1999) have studied the inhibition effect of andrographolide from 
Andrographis paniculata on PAF-induced platelet aggregation. It influenced the biosynthesis 
of eicosanoids and platelet activating factor. These results of andrographolide showed that the 
mechanism of action differs from NSAIDS drugs.[23] 
Hamgain RK (2000) has evaluated the treatment of acne vulgaris by herbomineral 
forms SK-34, SK-235 using student T tests. The study was for 8 weeks. At the end of 8th 
week none of the patients showed any skin reaction. SK-34 containing plants - Triphala, A. 
indica, Rubia cordifolia, Curcuma longa and Andrographis paniculata. SK-235 containing 
plants-Berberi saristatic Prones amygdalus and Aloe vera[24] 
Akbarsha MA and Murugaian P (2000) have studied the male reproductive toxicity 
and male anti fertility property of andrographolide in Wistar albino rats. On the testis and 
cauda epididymidal spermatozoa at two dose level for 48 days. It showed that sperm count 
decreased, spermatozoa were not motile. Andrographolide could affect spermatogenesis by 
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preventing cytokinese of the dividing spermatogenic cell lines, possible prospective use of 
andrographolide in male contraception have been suggested.[25] 
Rajini M et al., (2000) have isolated the andrographolide from the leaves of 
Andrographis paniculata by cold maceration (dichloromethane and methanol 1:1). The 
andrographolide from the extract were recrystallized and the compound was confirmed 
through IR, UV, MS, melting point and co-chromatography with reference standard.[26] 
Garg SC., (2000) has conducted an ethnobotanical survey on some medicinal plants 
for snake bite. More than 100 species like Artemisa vulgaris, Andrographis paniculata, 
Aristolochia bracteolate, Cissampelos pareria, Collocarpus epigaeus,Cynodon dactylon were 
used as antidotes for snake bite. These plants were competitive inhibitors of three basic 
phospholipase A2iso enzymes and adenosine triphosphotases enzyme for snake bite.[27] 
Mandal SC et al., (2001) have studied the psychopharmacological activity of the 
extract of Andrographis paniculata on experimental model. The extract exhibits alteration in 
behavior pattern and reduction in spontaneous motility and also produce prolongation of the 
pentobarbitone induced sleeping time and lower the temperature in animal model.[28] 
Trivedi NP and Rawal VM (2001) have studied the hepatoprotective and anti-
oxidant property of Andrographis paniculata (Nees) in BHC induced liver damage in mice. 
The administration of Androgaphis paniculata showed protective effect in the activity of 
superoxidase, glutathione peroxidase, glutathione reductase and lipid peroxidase .The results 
indicates that the plant possess anti-oxidant and hepatoprotective action.[29] 
Zaridah MZ et al., (2001) have studied in vitro anti-filarial effect of various plant 
species against adult worm of Subperiodic brugiamalayi. Five aqueous extract from 3 plant 
species (dried husk, dried seed, dried leaves of Xylocarpus granatum, dried stem of T. crispa 
and dried leaves of  Andrographis paniculata) were tested in vitro against adult worm of 
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Subperiodic brugiamalayi  over the 24h observation period, as a measure of anti -filarial 
activity.[30] 
Arya KR and Agarwal SC (2001) have reported the ethnobotanical survey of herbal 
folk remedy for piles used by patients of chronic piles during 1999-2001.[31] 
Lalla et al., (2002) have studied standardization of homeopathic mother tincture of 
Andrographis paniculata and investigated the organoleptic, physical, chemical property, 
HPTLC, using reference compound..[32] 
Kamdom RC et al., (2002) have studied the mechanism of superoxide scavenging 
activity of neo andrographolide from Andrographis paniculata. The neo andrographolide 
might scavenge free radical by donating the allyl dehydrogen of unsaturated lactone ring.[33] 
Ashok et al., (2002) have studied the effect of aging on andrographolide content in 
Andrographis paniculata by HPLC method. The best harvesting time was observed as 120 
days after sowing, to get higher biomass containing maximum andrographolide content.[34] 
Kumaranet al., (2003) have estimated the isolated andrographolide from 
Andrographis paniculata in rabbit serum by HPLC and UV-Vis spectrophotometric detector. 
Octa decylsilane column, methanol used as mobile phase and eluate were monitored at 
223nm. The absolute recovery of andrographolide ranged between 97.24-99.4%.[35] 
Singha PK et al., (2003) have evaluated antimicrobial activity of aqueous extract of 
Andrographis paniculata. The aqueous extract showed significant antimicrobial activity due 
to the combined effect of isolated arabinogalacton protein and andrographolide.[36] 
 Katyal M., (2003) have studied the phytochemical and pharmacological potential of 
Andrographis paniculata and this review provides consolidated information on chemical and 
biological profile of Andrographis paniculata.[37] 
Ha X et al., (2003) have isolated six new metabolites M-5-M-10 of andrographolide  
of Andrographis paniculata from rat urine. Metabolites are 14-deoxy-12(R)-
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sulfoandrographolide 3-sulfate(M-5),14-deoxy-12(S)-sulfoandrographolide 3-sulfate (M-6), 
14-sulfo isoandrographolide, 14-deoxy-11,12-di dehydroandrographolide (M-8), 
isoandrographolide (M-9) and 14-deoxy andrographolide (M-10), based on respective 
chemical evidence and spectroscopic analysis.[38] 
Saxena and UpadhyS., (2004) have reported the isolation and identification of 
flavonoidal glycoside from Andrographis paniculata. [39] 
Rao YK et al.,(2004) have identified  two flavonoids and andrographolide from the 
whole plant of Andrographis paniculata.5,7,2’,3’-tetra methoxyflavonone and 5-hydroxy -
7,2’,3’-tri methoxy flavone, andrographolide, diterpenoids, poly phenol were obtained from 
the whole plant of Andrographis paniculata.[40] 
Reddy BA et al., (2005) have isolated the two new flavonoids from whole plant of 
Andrographis microbotrye. The two flavonoids  are 5,7,8,2’-tetramethyl flavone (1)and 2-
hydroxy,2,3,4’-trimethylchalcone(3). The three flavones are 5-hydroxy-7-methoxy 
flavone,5,2’,6’-tri-hydroxy-methoxy flavone and5,7,2’,6’ tetra hyroxy flavone.  The structure 
of new compounds 1 and 3 have established by extensive 2D NMR.[41] 
 Reddy VLN et al., (2005) have evaluated anti-HIV activity and isolated 
bisandrographolide from Andrographis paniculata.  Six compounds of andrographolide,14-
deoxy-11,12-didehydroandrographolide, andrographanin,14-deoxy-11,12-didehydro 
andrographolide, 5-hydroxy-7,3-dimethoxy flavone, 5-hydroxy 7,8-dimethy flavone were 
isolated and tested for anti-HIV and cytotoxic activity.[42] 
Burgoseet al., (2005) have isolated 14-deoxy andrographolide from Andrographi 
spaniculata and observed platelet activating factor antagonistic activity in bovine 
neutrophils.14-DAP concentration between 10-100µg reduces the extracellular acidification 
rate and intracellular alkalination. 14-DAP reduced PAF-induced calcium influx in the 
presence of extracellular calcium and tyrosine phosphorylation ofa 44 KDA protein 
Chapter II                                                                        Review of Literature 
 
Department of Pharmacognosy, MMC. Page 20 
corresponding to the MAPK.  It was concluded that 14-DAP is an effective antagonist of PAF 
mediated process in bovine neutrophils.[43] 
Maiti K et al., (2006) have reported the therapeutic effect of andrographolide from 
the Andrographis paniculata. The andrographolide is a diterpene lactone which is responsible 
for various pharmacological activities like antioxidant, hypoglycemic etc.[44] 
Tan ML et al (2006) have evaluated cytotoxic activity of major diterpenoid 
consitituent of Andrographis paniculata in human cell lines. Seven compounds like 
andrographolide,14-deoxy andrographolide, andrographiside, deoxyandrographolide, 14-
deoxy-12-methoxy-andrographolide, neoandrographolide, 14-deoxy-11,12-didehydro 
andrographolide were evaluated in human tumor cell line.  14-deoxy andrographolide, 14-
deoxy-11,12-didehydro andrographolide exhibited cytotoxic activity.[45] 
Shariff A et al., (2007) have evaluated hepatoprotective activity of alcoholic extract 
of Andrographis paniculata.  The extract was entrapped into micro pellets of calcium alginate 
for masking bitter taste and the formed pellets were evaluated for hepatoprotective activity in 
paracetamol induced hepatotoxicity in rats. 22.5mg/kg body wt of alcoholic extract was given 
orally for 9 days and the activity was observed. This study showed that the extract 
successfully inhibit the paracetamol induced hepatotoxicity which was indicated by the 
decrease in AST, ALT, ALP.[46] 
 Chander R et al., (2008) have studied the Antidyslipedemic and Antioxident activity of 
SBC herbal formulation. It contains Terminalia bellirica, Terminelia chubula, Andrographis 
paniculata and Gymnema sylvertre. The administration of this drug at the dose 200mg/kg 
causes lowering in the level of cholesterol, phospholipid. Antidyslipedimic effect was 
compared with gemfibrozil. SBC also inhibit the formation of lipid peroxides in microsomes 
induced by non enzymic as well as enzymic system. [47] 
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Tomar A., (2008) collected the ethnobotanical survey of gastric disorder cured plants. 
Five species like Adenocalymna alliaceum, Andrographis paniculata, Barleria prionitis, 
Carica papaya, Cyperus rotundus were used as folk medicine in gastric pain by the rural 
people.[48] 
Kamble MB et al., (2008) have studied the hepatoprotective activity of aqueous and 
ethanolic extract of herbal formulation. Aqueous extract of Acacia catechu, Allium sativum 
and ethanolic extract of Andographis paniculata, Azadirachta indica, Boerhavia diffusa, 
Curcuma longa, Eclipta alba, Luffa echinata, Emlica officinalis, Phyllanthus amarus, 
Picrorrhiza kurroa were present in the formulation. The hepatoprotective activity was studied 
on acute liver toxicity models of CCl4 and paracetamol induced liver damage methods.49] 
Zhao F et al., (2008) have studied in-vitro method of anti-tumor activity of 
andrographolide from Andrographis paniculata by inducing Apoptosis and inhibiting VEGF 
level .It induced apoptosis of prostate cancer cells via the activation of caspase 3, up-
regulation of bax and down regulation of bcl-2.Its inhibitory activity on the level of vascular 
endothelial growth factor also verified by ELISA.[50] 
Bansel YK and Singh S., (2009) have developed the in-vitro propagation of 
Andrographis paniculata which was achieved through tissue culture. Different plant growth 
regulators were involved for regeneration. Explant was obtained from 20-25 days old 
seedlings. Cytokinin and  auxin were used for multiple shoot formation through MS medium 
with BAP.[51] 
Dua VK et al., (2009) have isolated four xanthones from the root of Andrographis 
paniculata which were tested for, in-vitro antiprotozoal activity against Trypanosome brucei 
and Leishmaniain fantum. The compound TDR 13011 showed significant activity against T. 
b. brucei and L. infantum with a 50% inhibitory concentration of 4.6µg/mL and 8µg/mL 
respectively.[52] 
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Chen JX et al., (2009) have studied in-vitro and in-vivo antiviral activity of 
andrographolide isolated from Andrographis paniculata against avian influenza virus.100-
200mg/kg dose level for 7 days. AL-1 was effective against avian influenza A and human 
influenza A (H1N1) virus in-vitro.AL-1 directly interfering with viral hemoagglutinin to 
block binding to cellular receptors.[53] 
Lin FL et al., (2009) have studied the anti-oxidant, antiedema, analgesic activity of 
aqueous and ethanolic extract of Andrographis paniculata. This plant was used as folk 
medicine for inflammation, fever, diarrhoea. The aqueous extract showed high concentration 
of total flavonoid but lower phenol content than the ethanolic extract. The aqueous extract 
showed more anti-oxidant activity and also potent anti-edema, analgesic activity.[54] 
Chao HP et al., (2010) have studied that the andrographolide exhibits anti invasive 
activity against colon cancer cells via inhibition of MMP2 activity. Andrographolide 
produced growth suppression, apoptosis, and promotion anti-angiogenesis and anti 
transformation. The invasion ability of CT 26 cells in matri gel based invasion assays.[55] 
Tanwar BS et al., (2010) have evaluated phytochemical and mollucicidal activity of 
Andrographis paniculata.  The powder and ethanolic extract showed LC50 at295.55mg/l.[56] 
Lima TB et al., (2010) have studied the hepatoprotective activity of Liv- 52 (Eclipta 
alba, Andrographis paniculata, Tinospora cordifolia, Boerhaavia diffusa, Berberis aristata) 
against carbon tetrachloride induced hepatotoxicity in albino rats.. The CCl4 (1ml/kg, i.p) was 
administered to animals for inducing the hepato toxicity, silymarin (25mg/kg. p.o) was used 
as standard. The total protein, glutathione were measured. The histopathological evaluation 
was also done and SGPT, SGOT, ALP, bilirubin level was also measured.  The extract 
exhibited protection of liver tissue and hepatoprotective activity.[57] 
Pannerselvam S et al., (2011) have evaluated the gastric protective efficacy of 
andrographolide from Andrographis paniculata in rats with duodenal ulcer induced by 
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cystamine administration (3mg/kg) for 30 days. The ulcer score measured in duodenal tissue. 
The study revealed that the andrographolide has potent antiulcer properties that was likely 
caused by minimum inflammatory changes counteracting free radical formation and maintain 
thiol redox status in the duodenum.[58] 
Alagesaboopathi C and Balu S (2000) have studied anti-fungal activity of leaves of 
some species of Andrographis wallich ex Nees on Helminthosporium oryzae Breda dehaan 
by spore germination and agar cup bioassay methods. The plant species evaluated are 
Andrographis paniculata, Andrographis alata, Andrographis microbotrys, Andrographis 
neesiana. All the five extracts inhibited the test fungi and the Andrographis microbotrys was 
found to be more effective.[59] 
Andrographis elongate 
Jeyakrishna G et al., (2001) have isolated new 2’-oxygenated flavones from 
Andrographis elongate. 5,2’,6’-tri-hydroxy 7-methoxy flavone & skull cap flavone 1,2’-O-β-
D-(4’-E-cinnamyl glucopyranoside, 7-methy wogonin, skull cap flavones 1,2’-O-β-D-
glucopyranoside. The structures were elucidated by FAB-MS and (1D and 2D)-NMR 
studies.[60] 
Andrographis viscosula 
Rao YK et al., (2002) have isolated 5, 7, 2’-trimethoxy flavones (1) and 5, 7, 2’, 4’, 
6’-penta methoxy flavone from the whole plant of Andrographis viscosula. The three 
flavones are echioidinin, 5, 2’, 6’-tri hydroxyl-7-methoxy flavone and echioidin. These 
compounds were elucidated on the basis of ID and 2D NMR spectral studies.[61] 
Andrographis alata 
Das B et al., (2006) have isolated the five acylated 5, 7, 2’, 6’,-oxygenated flavone 
glycosides from the whole plant of Andrographis alata.5,2’, 6’-tri-hydroxy- 7-methoxy 
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flavone-2’-o-beta-D-gluco pyranoside. The structure of the compounds were established from 
spectral (1D and2D NMR) and chemical studies.[62] 
Andrographis stenophylla 
Thangavel N and Gupta JK., (2007) have studied anti- inflammatory and anti –
snake venom activity of methanolic extract of Andrographis stenophylla using carrageenan-
induced acute pedal paw edema model and Freund’s adjuvant induced chronic inflammatory 
model. The dose level of 50 and 100mg/kg extract showed anti -inflammatory activity and 
the leaf extract was found to potentiate the polyvalent snake venom anti serum action in 
experimental animal.[63] 
Andrographis serphyllifolia 
Ravishankar K and Rao BG., (2008) have evaluated the anti-inflammatory activity 
of the ethanolic root extract of Andrographis serphyllifolia in experimental rat.  The dose 
level of 200mg/kg of the ethanolic extract shows maximum inhibition (38-95%) in 
carageenan- induced rat paw oedema as compared with the standard diclofenac sodium( 57-
80%) after 3hr of carrageenan injection. Ethanolic extract significantly inhibit the histamine 
induced rat paw edema.[64] 
The review of literature revealed that fragmentary information was available on 
Andrographis echioides while much information was available on Andrographi spaniculata. 
Hence the present study was planned to explore the pharmacognostic, phytochemical and 
pharmacological activity of the whole plant of Andrographis echioides (L) Nees. 
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CHAPTER 3 
PLANT PROFILE [65-67] 
BOTANICAL SOURCE :  Andrographis echioides(L.) Nees 
FAMILY                       :  Acanthaceae 
SYNONYMS                      :  Indoneesiella echioides (L) Sreemadh 
    Justicia echioides L. 
Andrographis echioides is an erect herbs growing to a height of 10-50cm. The whole 
plant is villous with the leaves being opposite decussate, elliptic, oblong, and obtuse to round 
at apex, attenuate at base and 7.5cm long, 2.4cm wide. The flowers appear during March-
June and October-December.  
SYSTEMATIC POSITION 
Kingdom   : Plantae 
Subkingdom   : Trachiobionta 
Infra kingdom   : Streptophyta 
Phyllum   :  Tracheophyta 
Class    :  Magnoliatae 
Subclass   :  Asteridae 
Order                              : Scrophulariales 
Suborder   : Asteranae 
Family                             :  Acanthaceae 
Subfamily   :  Acanthoideae  
Tribe                               : Ruellieae 
Subtribe   :  Andrographinae 
Division                          :  Magnoliophyta 
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Subdivision   :  Spermatophyta  
Genus    :  AndrographisWall.exNees 
Species       :  Andrographis echioides 
COMMON NAME 
 English             :  False water willow 
VERNACULAR NAMES 
Tamil      :  Gopuramthangi, Malaithangi 
Malayalam      :  Pituma 
Telungu   :  Tellavemu 
Gujarathi   :  Kalukariyatun 
Marathi           :  Ranchimani 
Oriya               :  Lavalata 
Others             :  False water willow 
Geographical Distribution and Occurrence 
Andrographis echioides is distributed in the tropical India and Srilanka. It is found in 
several regions in Tamil Nadu and Kerala like Kannur, Kottayam, Alappuzha, Kollam, 
Palakad, Thiruvananthapuram and Madurai.   
Habit and Habitat: 
 Andrographis echioides is an annual herb found in South India. 
Ethnomedical Information for whole plant: 
1. The whole plants are used for scorpion sting, snake bite and stomach ache. 
2. The leaves are used for cuts and fever. 
3. The herb is used for the treatment of dysentery, diabetes, swellings, liver damage and 
jaundice.   
4. The juice of the leaves is used for hair falling and hair growth. 
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CHAPTER 4 
AIM AND SCOPE OF THE STUDY [68, 69] 
The ethnomedical information revealed that almost whole plant is used in various 
indigenous system of medicine against several diseases. 
Andrographis (Acantaceae) is a genus of about 40 species. Several Andrographis 
species have been used in the treatment of dyspepsia, influenza, malaria, respiratory 
infections, antidote for poisonous stings, diabetes and urinary tract infections. 
Andrographis echioides (L) Nees is a procumbent annual herb, the plant have 
properties similar to those of Andrographis paniculata. The herb is useful for the treatment of 
dysentery, diabetes, swelling and also used for liver damage,jaundice, cuts and fever.  
The present study has been designed to carry out the pharmacognostical, 
phytochemical and pharmacological evaluation of whole plant of Andrographis echioides. 
1. Detailed pharmacognostical studies of whole plant of Andrographis echioides. 
2. Preliminary phytochemical studies on the extracts in order to confirm the presence 
of primary and secondary metabolites like phenol, flavonoids tannins. 
3. Estimation of the total phenol, flavonoid, tannins and vitamin content in 
Andrographis echioides extract. 
4. Phytochemical evaluation of the extract by means of the TLC and HPTLC studies. 
5. Determination of Mineral (or) heavy metals using X-Ray fluorimetry. 
6. Evaluation of the extracts of the plant Andrographis echioides for the following 
pharmacological studies. 
(a) Determination of in-vitro antioxidant potential by, 
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1. DPPH Assay 
2. Hydrogen peroxide scavenging activity 
3. Ferric reducing Antioxidant power (FRAP) Assay 
4. Reducing power Assay 
   5. Total Antioxidant activity by phospho molybdenum method. 
(b) To study in-vitro calcium oxalate crystallization inhibition by ethanolic
 extract of Andrographis echioides. 
(c) To study in-vitro anti-diabetic activity of Andrographis echioides extract. 
(d) To study the in-vitro anti-bacterial activity of Andrographis echioides. 
(e) To study the in-vitro anti-fungal activity of Andrographis echioides. 
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CHAPTER - 5 
PHARMACOGNOSTIC STUDIES 
Pharmacognostical evaluation gives valuable information regarding the morphology, 
microscopical and physical characteristics of the crude drugs and the resulting observations 
have been incorporated in various pharmacopoeias. There are number of plants whose 
identity, pharmacognostic studies and medicinal properties have not yet been scientifically 
studied. Hence pharmacognostic study gives the scientific information regarding the purity 
and quality of the plant drugs. 
MATERIALS AND METHODS 
SECTION A - MACROSCOPICAL STUDIES 
Morphological studies include aspects of outward appearance (shape, structure, 
colour, and pattern) as well as the form and structure of the various parts like leaves, flowers 
etc. Some of these gross morphological characters of the drugs such as shape, size, margin, 
apex and venation are identification features of the drugs. These features give valuable 
information about the drugs.   
Collection of Plant Material 
The plant specimens were collected from Madurai Medical College campus. The plant 
was identified and authenticated by Dr. L. Stephen, Lecturer, American College, Madurai. 
The authenticated herbarium sheet has been placed at the Dept. of Pharmacognosy, College 
of Pharmacy, Madurai Medical College. A copy of the herbarium has been presented in 
Fig.1A special care was taken to select healthy plants and normal organs for macroscopical 
studies. The macroscopical features of the plant are presented were in Fig.2.1 to 2.4. The 
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whole plant material was washed thoroughly and dried in shade. The shade dried plant 
material were powdered and used for further studies.  
SECTION B - MICROSCOPICAL STUDIES 
The microscopical study of organized crude drugs is an important parameter for 
evaluation. The microscopicalevaluation allow more detailed examination of the plant 
material to identify the organized drug by its histological character. It provides detailed 
information about the crude drugs by virtue of its property to magnify the fine structures of 
minute objects to be visualized and thereby confirm the structural details of the plant drug 
under evaluations. It can also be used in the determination of the optical as well as micro 
chemical properties of the crude drug.  
Material and Methods. 
Collection of Specimen 
The leaves, root, stem of the plant were subjected tomicroscopicalevaluation.The 
samples of the leaf were cut and removed from the plant and fixed in FAA (formalin-
5ml+acetic acid-5ml+70%ethyl alcohol-90ml). After 24h of fixing, the specimens were 
dehydrated with graded series of tertiary-butyl alcohol [70]. The infiltration of the specimens 
was carried by gradual addition of paraffin wax (melting point 58-60°C) until TBA solution 
attained super saturation. The specimens were then cast into paraffin blocks. 
Sectioning 
The paraffin embedded specimen was sectioned with the help of rotary microtome. 
The thickness of the sections was 10-12µm, de-waxing of the sections was carried out by 
customary procedure [71]. The sections were then stained with toludine blue, [72]  Since 
toludine blue is a polychromatic stain, the staining results were remarkably good; and some 
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cytochemical reactions were also obtained. The dye rendered pink colour to the cellulose 
walls, blue to the lignified cells, dark green to suberin, violet to the mucilage, blue to the 
protein bodies etc. The sections were also stained with saffranin and fast-green and iodine 
wherever necessary. 
For studying the stomata morphology, venation pattern and the trichome distribution, 
paradermal sections (sections taken parallel to the surface of leaf) was used. The clearing of 
leaf with 5% sodium hydroxide or epidermal peeling by partial maceration employing 
Jeffrey’s  maceration fluid were also prepared for studying stomatal morphology. Glycerin 
mounted temporary preparations were made for macerated/ cleared material. The powdered 
materials of different parts were cleared with sodium hydroxide and mounted in glycerin 
medium after staining. Different cell components were studied and measured. 
Photomicrographs 
Photographs of different magnifications were taken with Nikon lab photo 2 
microscopic units. For normal observation bright field was used. For the study of crystals, 
starch grains and lignified cells, polarized light was employed. Since these structures have 
birefringent property, under polarized light they appear bright against dark background. The 
magnification of the figures was indicated by the scale bars on the photomicrographs. The 
microscopic features observed for the leaves of the plant are presented in Fig. 3 to 8. 
SECTION C - QUANTITATIVE MICROSCOPY 
Quantitative microscopy or determination of some pharmacognostic parameters is 
useful for setting standards for crude drugs. This is used for evaluation, identification, 
characterization and standardization of crude drugs. A clear idea about the identity and 
characteristic features of the drug can be obtained after several number of determinations. 
The characteristic’s number obtained is noted and compared with a standard value to find out 
whether it is within the range and standard deviation. 
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DETERMINATION OF LEAF CONSTANTS [73-77] 
The stomatal number, stomatal index, vein islet number and vein termination number 
were determined on fresh leaves by using standard procedures.  
Stomatal number and stomatal index 
The stomatal number (SN) and stomatal index (SI) is a very specific criterion for 
identification and characterization of leaf crude drugs. 
Stomatal number 
 The average number of stomata present in one square millimeter area of each surface 
of a leaf epidermis is termed as stomatal number.[74]. 
Stomatal index 
The stomatal index is the percentage of the number of stomata to the total number of 
the epidermal cells, each stomata being counted as one cell. The stomatal index was 
calculated using the formula S.I = (S/E+S) × 100; where S = Number of stomata per unit 
area; E = Number of epidermal cells in the same unit area. 
Procedure 
 The upper and lower epidermis was peeled out separately by means of forceps. The 
cleared leaf was placed on a slide and mounted in glycerin. A camera lucida and drawing 
board was placed and a stage micrometer was inserted for making the drawing scale. A 
square of 1mm was drawn by means of stage micrometer. The slide with cleared leaf 
(epidermis) was placed on the stage of the microscope and examined under 45X objective 
and 10X eye piece. The epidermal cells and stomata was traced. The numbers of stomata 
present in the area of 1 sq. mm. including the cell if at least half of its area lies within the 
square was counted. The result for each field was calculated and the average number of 
stomata per sq. mm. The results obtained are tabulated in table 1. 
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For stomatal index, the glycerin mounted leaf peeling as mentioned above was made and 
circle (O) like mark for each stomata and a cross (X) like mark for each epidermal cells was 
marked on the chart paper. The results obtained are tabulated in table 1. 
Vein islet number and vein termination number 
Vein islet number  
It is the average number of vein-islets per square mm of the leaf surface. It is 
determined by counting the number of vein-islets in an area of 4sq.mm of the central part of 
the leaf midway between the midrib and the margin. 
Vein termination number [75] 
Vein termination number is the average number of veinlet termination present in per 
sq.mm of the leaf surface. It is determined by counting the number of vein terminations in an 
area of 4sq.mm of the central part of the leaf midway between the midrib and the margin. 
Procedure: 
The fragments of leaves, about 5x5 mm in size, from middle and lamina portion was 
placed in a test tube containing about 5 ml of chloral hydrate and heated on water bath for 
about 15 minutes or until the fragments are transparent. The cleared fragments were stained 
with saffranin solution and a temporary mount was prepared with glycerol solution. The stage 
micrometre placed on the microscopic stage, examined under 10X objective and 6X eye piece 
and an area of 1 sq mm square was drawn. The cleared leaf piece was placed on the 
microscope stage, the vein islets and vein terminals included in the square was drawn. The 
number of vein islets and terminals within the square were counted. The results obtained in 
the number of vein islets and terminals in 1sq.mm. The results obtained are tabulated in 
table1. 
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SECTION D - POWDER ANALYSIS AND MICROSCOPY  
Powder analysis 
The behavior of the powder with different chemical reagents was carried out as per 
standard procedure [74] and the results are presented in table 2. 
Fluorescence analysis  
The fluorescent analysis of the drug powder as well as the plant extracts of 
Andrographis echioides were carried out and the observations are tabulated in table 3. 
Powder microscopy 
 The powder was observed under a microscope and the various characteristic features 
observed under the microscope is presented in Fig. 9. 
SECTION E - STANDARDIZATION PARAMETERS [77] 
The determination of the ash values, loss on drying, foreign organic matter and 
extractive values etc. gives a clear idea about the specific characteristics of crude drug under 
examination, besides its macro-morphological or cyto-morphological, microscopical nature in 
both its entire and its powder form. These diagnostic features enable the analyst to know the 
nature and characteristic of crude drugs. The procedures recommended in Indian 
Pharmacopoeia were followed to calculate total ash, water-soluble ash, acid-insoluble ash, 
sulphated ash and loss on drying at 110oC. The percentage of extractive values for different 
solvents was also calculated. 
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Determination of foreign organic matter  
The part of organ or organs other than those specified in the definition or description 
of the crude drugs is defined as foreign organic matter. An accurately weighed 100g of air 
dried coarse drug and spread out in a thin layer. The sample drug was inspected with the 
unaided eye or with the use of 6X lens and the foreign organic matter was separated manually 
as completely as possible and weighed. The percentage of foreign organic matter was 
calculated with reference to the weight of the drug taken. The results obtained are presented 
in table 4. 
Determination of Moisture Content (Loss on Drying)  
An accurately weighed 10g of powdered drug was placed in a tared weighing bottle. 
Then the bottle was dried at 105oC for 5h and weighed. The drying and weighing was 
continued at one hour intervals until the difference between the two successive weighing is 
not more than 0.25%. The loss on drying was calculated with reference to the amount of 
powder taken. The results obtained are presented in table 4. 
Determination of Ash values    
Ash Content [76]    
The residue remaining left after incineration of the crude drug is designated as ash. 
The residue obtained usually represents the inorganic salts naturally occurring in the drug and 
adhering to it. It varies within definite limits according to the soils where the plant material is 
generally collected. It may also include inorganic matter deliberately added for the purpose of 
adulteration. Hence, an ash value determination furnishes the basis for judging the identity 
and cleanliness of any drug and gives information relative to its adulteration/contamination 
with inorganic matter, thus ash values are helpful in determining the quality and purity of 
drug. 
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Procedure 
Determination of Total Ash 
An accurately weighed about 2g of air dried powdered drug was taken in a tared silica 
crucible and incinerated at a temperature not exceeding 450oC, upto 6h until free from carbon 
the cooled and weighed, repeated for constant value. Then the percentage of total ash was 
calculated with reference to the air-dried drug. The results obtained are presented in table 4. 
Determination of Acid Insoluble Ash 
The ash obtained as directed under total ash was boiled with 25mL of 2M 
hydrochloric acid for 5min on a water bath, and then the insoluble matter was collected on an 
ashless filter paper (Whatmann) and washed with hot water, dried and ignited for 15min at a 
temperature not exceeding 450oC, cooled in a dessicator and weighed. The percentage of acid 
insoluble ash with reference to the air-dried drug was calculated. The results obtained are 
presented in table 4. 
Determination of Water Soluble Ash 
The ash obtained as directed under total ash was mixed with 25mL of water and 
boiled for 5min in a water bath, and then the insoluble matter was collected in an ashless 
filter paper and washed with hot water, dried and ignited for 15min at a temperature not 
exceeding 450oC, cooled in a dessicator and weighed. The insoluble matter was subtracted 
from the weight of the total ash; the difference in weight represents the water soluble ash. 
The percentage of water soluble ash was calculated with reference to the air dried drug. The 
results obtained are presented in table 4. 
Determination of sulphated Ash  
An accurately weighed 2g of air dried powdered drug in a tared silica crucible which 
was previously ignited and cooled before weighing at a temperature not exceeding 450°C. 
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The residue was moistened with 1mL of concentrated sulphuric acid, ignited at 800 ± 25°C 
until all black particles have disappeared. It was then cooled; again sulphuric acid was added 
and ignited. It was cooled and the percentage of sulphated ash was calculated with reference 
to air dried drug. The results obtained are presented in table 4. 
Extractive values [76] 
Extractive values help to determine the amount of soluble active constituents in a 
given amount of medicinal plant material, when extracted with solvents. The extraction of 
any crude drug with a particular solvent yields a solution containing different 
phytoconstituents. The composition of these phytoconstituents in that particular solvent 
depends upon the nature of drug and solvent used. The use of single solvent can also be used 
for providing preliminary information on the quality of a particular drug sample and hence is 
an important tool for analysis of plant crude materials for its identity, purity and quality.  
Procedure 
Determination of ethanol soluble extractive 
An accurately weighed 5g of the air dried coarsely powdered drug was macerated 
with 100mL of ethanol in a closed flask for 24h, shaking frequently during the first 6h and 
allowed to stand for 18h. Thereafter filtered rapidly, taking precautions against loss of 
ethanol. Then evaporate 25mL of the filtrate to dryness in a tared china dish dry at 105oC and 
weighed. The percentage of ethanol soluble extractive was calculated with reference to the air 
dried drug. The results obtained are presented in table 4. 
Determination of water soluble extractive 
An accurately weighed 5g of the air dried coarsely powdered drug was macerated 
with 100mL of chloroform water in a closed flask for 24h, shaking frequently during the first 
6h and allowed to stand for 18h. Thereafter filtered rapidly, taking precautions against loss of 
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chloroform water. Then evaporate 25mL of the filtrate to dryness in a tared china dish dry at 
105oC and weighed. The percentage of water soluble extractive was calculated with reference 
to the air dried drug. The results obtained are presented in table 4. 
Determination of petroleum ether soluble extractive 
The procedure adopted under ethanol soluble extractive was followed using petroleum 
ether as a solvent. The results obtained are presented in table 4. 
Determination of hexane soluble extractive 
The procedure adopted under ethanol soluble extractive was followed using hexane as 
a solvent. The results obtained are presented in table 4. 
Determination of chloroform soluble extractive 
The procedure adopted under ethanol soluble extractive was followed using 
chloroform as a solvent. The results obtained are presented in table4. 
Determination of benzene soluble extractive 
The procedure adopted under ethanol soluble extractive was followed using benzene 
as a solvent. The results obtained are presented in table 4. 
Determination of ethyl acetate soluble extractive 
The procedure adopted under ethanol soluble extractive was followed using ethyl 
acetate as a solvent. The results obtained are presented in table 4. 
Determination of acetone soluble extractive 
The procedure adopted under ethanol soluble extractive was followed using acetone 
as a solvent. The results obtained are presented in table 4. 
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Determination of Foaming Index  
 Some plant materials when shaken with water cause persistent foam which may be 
attributed to the presence of saponins in that material. The foaming ability of an aqueous 
solution of plant materials and their extracts is measured in terms of foaming index.  
Procedure 
An accurate quantity of about 1g of the coarse plant material was weighed and 
transferred into an Erlenmeyer flask containing 100mL of boiling water. The flask was boiled 
at moderate heat for 30min. The solution was cooled and filtered into a 100mL volumetric 
flask and sufficient distilled water was added to dilute to volume. The solution was poured 
into ten stoppered test tubes in successive portions of 1mL, 2mL, etc. upto 10mL, and the 
volume of the liquid in each tube was adjusted with water upto 10mL. The tubes were then 
stoppered and shaken in a length wise motion for 15sec (two shakes/sec) and allowed to stand 
for 15min. The height of foam was measured.  If the height of the foam in every tube was less 
than 1cm the foaming index was less than 100. If a height of foam of 1cm was measured in 
any test tube, the volume of the plant material decoction in this tube (a) was used to 
determine the index.  If the height of the foam was more than 1cm in every tube, the foaming 
index was over 1000. In this case, the determination was repeated using a new series dilution 
of the decoction in order to obtain a result. The foaming index was calculated by using the 
following formula 1000/A where A was the volume in mL of the decoction used for 
preparing the dilution in the tube where foaming to a height of 1cm was observed. The results 
obtained are presented in table 4. 
Determination of volatile oil 
 Volatile oils are characterized by their odour, oil like appearance and also it has 
ability to volatilize at room temperature. Chemicaly they are mixture of monoterpenes, 
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sesquiterpenes and their oxygenated derivatives. Volatile oils are estimatedby hydro-
distillation method using a standard procedure.    
 
RESULTS AND DISCUSSION 
SECTION A - MACROSCOPICAL STUDIES 
Observations and discussion 
Leaves (Fig.2.2 & 2.3) 
Andrographis echioides is an erect herb growing to a height of 10-50cm. The leaves 
are hairy on both sides. The whole plant is villous with the leaves being opposite decussate, 
elliptic oblong, obtuse to round at apex, attenuate at base and 7.5cm long, 2.4cm wide. It is a 
small herb, four sided, it looks like temple tower and the leaves are greenish with red patches. 
Flowers (Fig.2.4) 
Flowers are borne in spike-like racemes, up to 2cm long. The stalk carrying the 
raceme is densely hairy. Flowers are erect. Sepal tube is 2mm long, with thread-like sepals up 
to 9mm long. Flowers have a 4mm long tube, opening into two lips. Upper lip is oblong, up 
to 5.5 x 2mm, 2-lobed above. Lower lip is up to 7mm long, with 3 oblong-lance shaped lobes, 
marked with purple. Stamen filaments are flattened. The flowers appear during March-June 
and October-December.  
Seeds 
The seeds are 0.15-0.2 cm long, black, pitted without retinacula spiny. 
Organoleptic evaluation 
 Nature    - Coarse Powder 
 Colour  -   Light green 
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FIG: 2.5  DIAGRAMETIC REPRESENTATION OF Andrographis echiodes (L.) Nees 
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 Odour  - Characteristic 
 Taste   - Bitter 
SECTION B - MICROSCOPICAL STUDIES 
Midrib of the leaf (Fig.3.1, 2) 
The leaf has a thick and prominent midrib (Fig.3.1).The midrib has thick, dorsiventral 
lamina, rectangular adaxial part and wide expanded abaxial part (Fig 3.2). The midrib is 
600µm thick and the adaxial part is 300µm wide, the abaxial part is 600µm wide. The midrib 
is thick and comprises of rectangular thin walled cells. The ground tissue is parenchymatous, 
the cells are angular thin walled and compact. The mesophyll tissue is horizontally trans 
current along adaxial part of the midrib.(Fig.3.2). The vascular strand is single, concave disc, 
measuring 150µm thick and 350µm wide. The vascular strand is collateral with adaxial, 
several parallel lines of xylem elements and abaxial phloem elements.  The phloem elements 
are in small discrete nests (Fig.3.2).The xylem elements are narrow, angular in outline, thick 
walled and are arranged in long multiples. 
The lateral vein (Fig.4.1) 
The lateral vein is planoconvex with flat adaxial side and thick conical adaxial part 
(Fig.4.1). The lateral vein has a single, small and collateral vascular bundle. The vein is 300 
µm thick (Fig.4.1).    
Lamina (Fig.4.2, 3) 
The lamina is 110µm thick. The adaxial epidermis fairly thick and the cells  are 
rectangular and thin walled. Multicellular, uniseriate, un-branched non-glandular trichomes 
are seen arising from adaxial epidermis (Fig.4.2). The abaxial epidermis comparatively thin 
and the cells are cylindrical. The mesophyll tissue consists of adaxial, single row of loosely 
arranged palisade cells and abaxial spongy parenchyma cells of lobed and less compact 
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tissue. The leaf margin is thick, bluntly conical (Fig.4.3).  The epidermal cells along the 
marginal part are lightly dilated into large rectangular or squarish cells with prominent 
cuticle. The palisade and spongy mesophyll tissues are retained in the marginal lamina. 
Stomata and epidermal cells (Fig.5.1, 2, 3) 
 Some of the epidermal cells of the lamina are modified into elongated wide cells 
called lithocysts. Within the lithocyst occurs thick, cylindrical cystolith. The surface of the 
cystolith is echinate. (Fig. 5.1). 
The epidermal cells have wavy thick anticlinal walls. (Fig.5.2).The stomata are 
diacytic type. There are two subsidiary cells, lying on the ends of the guard cells, the 
common wall of the subsidiary cells is at right angles to the guard cells.(Fig.5.2, 3). The 
guard cells of the stomata are 10x20µm in size. 
Venation Pattern (Fig.6.1, 2) 
The veins are thin and straight, they form wide vein-islets of rectangular outline. The 
islets are more or less parallel to each other. The vein-terminations are branched long, slender 
undulate (Fig.6.2). 
Stem (Fig.7.1, 2) 
The stem is four angled with thick conical ridges at the corners (Fig.7.1).The stem is 
2mm thick. The stem consists of a thick and distinct epidermal layer of squarish thin walled 
cells. The cortical zone is narrow and includes about six layerof angular thin walled 
parenchyma cells. Secondary phloem occurs in the continuous layer on the outer 
circumference of the secondary xylem cylinder. Secondary xylem cylinder is thicker along 
the corner of the stem and thin in between the corners (Fig.7.2). Xylem consists of numerous 
solitary, diffuse vessels. The vessels are circular and thick walled. The vessels are both 
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narrow and wide type. Xylem includes xylem fibre,which are thick walled and lignified. The 
vessels are 20-40µm wide. The pith is wide and consists of compact, thin walled parenchyma 
cells. 
Root (Fig.8.1, 2) 
The root is circular in sectional view, measuring 850µm thick. The epidermis is 
crushed and obliterated forming a thick dark line on the surface the root. (Fig.8.1). One or 
two large thin walled cortical layers of cells which are intact. Secondary phloem occurs in 
small, isolated masses distributed along the peripheral part of the xylem. 
 Secondary xylem occupies the major portion of the root. It consists of dense 
distribution of vessels which are circular to elliptical, thick walled and mostly solitary. The 
ground tissue of the secondary xylem cylinder is the fibres which are narrow and dense. The 
vessels in the central part of the root are narrow and they become wider towards the pericarp. 
The vessels are 20-60µm in diameter.  
SECTION C - QUANTITATIVE MICROSCOPY 
 The results obtained for various leaf constants like stomatal number, stomatal index, 
vein islet and vein termination number were presented in table 1.  
Table 1 : Quantitative microscopical parameters of the  
leaf of Andrographis echioides 
 
S. No. Parameters* Values 
obtained* 
1 Stomatal number  in upper epidermis  35.34 ± 1.47 
2 Stomatal number  in lower epidermis  53.42 ± 2.12 
3 Stomatal index in upper epidermis  16.51 ± 0.11 
4. Stomatal index  in lower epidermis  18.96 ± 0.60 
5. Vein islet number    8.90 ± 0.42 
6. Vein termination number  21.00 ± 1.08 
* Values are mean of 10 readings ± SEM 
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From the table 1, it can be observed that the stomatal number was 35.34 ± 1.47  and 53.42 ± 
2.12, while the stomatal index was 16.51 ± 0.11 and 18.96 ± 0.60 for upper and lower 
epidermis respectively. The vein islet number and vein termination number was found to be 
8.90 ± 0.42 and 21.00 ± 1.08 respectively. 
SECTION D - POWDER ANALYSIS AND MICROSCOPY 
POWDER ANALYSIS  
The observations of the powder in day light and in UV light with various chemicals 
and reagents were presented in table 2.  
Table 2: Behavior of the Andrographis echioides(L) Nees.powder 
with various chemicals and reagents 
 
Drug powder + reagent Colour in day 
light (Visible) 
Colour in UV light  
254nm 365nm 
Powder Pale green Green Black 
Powder + 1M sodium hydroxide Pale green Dark green Brown 
Powder + Iodine  Green color Dark green Dark green 
Powder + 10% potassium 
hydroxide 
Pale green Green  Greenish black 
Powder + 1M Hydrochloric acid Brown  Dark brown Black  
Powder + Glacial acetic acid Brownish green Brown  Orange 
Powder + 50% sulphuric acid Brown Dark brown Dark brown 
Powder + 50% nitric acid Brownish green Green  Bluish black 
Powder + 50% hydrochloric acid Pale yellow Brown  Dark brown 
Note :-Colour reactions are viewed under natural light by naked eye 
From the table 2, it can be seen that when the powder was treated with alkalis like 
sodium hydroxide and potassium hydroxide was pale green in daylight and green at 254nm 
and greenish black at 365nm and when treated with hydrochloric acid and sulphuric acid, the 
Chapter V                                                                   Pharmacognostic Studies  
 
Department of Pharmacognosy, MMC. Page 45 
powder appeared brown to brownish yellow in day light and brown to dark brown under UV. 
The powder appeared orange under UV light at 365nm when treated with glacial acetic acid. 
FLUORESCENCE ANALYSIS 
The fluorescence analysisof the extracts in day light and in UV light were presented in 
table 3.  
Table 3: Fluorescence analysis of extracts of Andrographis echioides (L)Nees 
Extract Consistency 
Colour in day 
light 
Colour in UV light 
254nm 365nm 
Ethanol Semisolid Green Dark green Orange 
Pet ether Semisolid Pale yellow Fluorescent green Green 
Chloroform Semisolid Brownish green Greenish black Orange 
Ethyl acetate Semisolid Green Brown Orange 
Water Semisolid Pale yellow Dark green Fluorescent green 
Benzene Semisolid Yellow Green Orange 
Hexane Semisolid Green Green Brown 
Acetone Semisolid Green Dark green Orange 
  
From the table3, it can be observed that the aqueous extract and petroleum extract 
were fluorescent green in UV light at 365nm and 254nm respectively. The chloroform, ethyl 
acetate, benzene and acetone extracts appeared orange in UV light at 365nm. These 
observations will be useful for determining the purity of the sample in future and helps in 
preparing standards for this plant. 
POWDER MICROSCOPY 
The various characters seen under the microscope are presented in Fig. 9. The 
characteristic features observed included stomata, trichomes (multicellular, uniseriate, 
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unbranched), cystoliths, xylem vessels, xylem fibres,  parenchyma cells, epidermal cells and 
palisade cells 
SECTION E - STANDARDIZATION PARAMETERS 
 The results obtained for the various standardization parameters like foreign organic 
matter, moisture content, ash values, extractive values, volatile oil and foaming index were 
presented in table 4. 
Table 4: Standardization parameters of Andrographisechioides(L) Nees. 
S. No Parameters* Values*expressed as % 
1 Foreign organic matter   0.01 ± 0.02 
2 Moisture content   5.73 ± 0.066 
3 Ash values   
 Total ash  14.38 ± 0.003 
 Acid insoluble ash   2.96 ± 0.006 
 Water soluble ash    4.83 ± 0.010 
 Sulphated ash   7.74 ± 0.010 
4 Extractive Values  
 Petroleum ether 24.68 ± 0.001 
 Chloroform    7.46 ± 0.008 
 Ethyl acetate   5.88 ± 0.010 
 Ethanol   5.76 ± 0.008 
 Acetone   5.97 ± 0.010 
 Water 22.07 ± 0.010 
 Hexane   3.87 ± 0.008 
 Benzene   6.24 ± 0.003 
5 Foaming index 100 
6 Volatile oil Nil 
  
From the results in table 4, it can be seen that the moisture content was found to be   
5.73 ± 0.066 which is within the prescribed limits. If the moisture content was more, then it 
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would lead to microbial growth and hence loss of active principles thus leading to loss of 
pharmacological activity. 
 The total ash was found to be 14.38 ± 0.003 while the acid insoluble ash, water 
soluble ash and sulphated ash was found to be 2.96 ± 0.006, 4.83 ± 0.010  and 7.74 ± 0.010 
respectively. The determination of ash values helps in the determination of quality and purity 
of the crude material in powder form at a future date. 
 The water soluble extractive value was found to be 22.07 ± 0.010 while the petroleum 
ether soluble extractive value was found to be 24.68 ± 0.001.  
 The standardization parameters determined will add weightage to the 
pharmacognostic parameters and will be useful for identification of adulterants, 
determination of quality of the plant material in crude form in future. 
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CHAPTER- 6 
PHYTOCHEMICAL EVALUAITON 
A phytochemical is a compound found in plants that works with nutrients and dietary 
fiber to protect against disease. They also slow the aging process. Phytochemical screening is 
a process of tracing plant bioactive principles of plant to discover their medicinal benefits. 
 Plants produce a vast and diverse assortment of organic compounds, the great 
majority of which do not appear to participate directly in growth and development. These 
substances, traditionally referred to as secondary metabolites, often are differentially 
distributed among limited taxonomic groups within the plant kingdom. Their functions, many 
of which remain unknown, are being elucidated with increasing frequency. The primary 
metabolites such as phyto-sterols, acyl lipids, nucleotides, amino acids, and organic acids 
found in all plants and perform metabolic roles that are essential and are evident. Secondary 
metabolites are responsible for medicinal activity of plants and hence phytochemical 
screening and identification of bio active principle in medicinal plants were carried out in 
extract using standard procedure. [78-82]  
MATERIALS AND METHODS   
Preparation of Extract 
About 500g of the dried whole plant powder was defatted with 1.5L petroleum ether 
(60-800 C) by maceration.  The solvent was removed by filtration and the marc was dried. To 
the dried marc 1.5L of 70% ethanol was added and the extraction was performed by triple 
maceration (72h process).  It was then filtered and the combined filtrate was evaporated to a 
cohesive mass using rotary evaporator. 
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SECTION A - PRELIMINARY PHYTOCHEMICAL SCREENING  
 
Qualitative chemical tests are carried out for the purpose of specific identity of the 
substances in the crude extracts. The color reaction or precipitate usually observed can 
identify a class of compound. Chemical tests can be useful for the investigation of the 
chemical compounds and to observe the efficiency of an extraction process.  
The ethanolic extract was subjected to preliminary phytochemical screening. The 
various chemical tests performed on the extracts were for steroids, triterpenoids, flavonoid, 
carbohyrates, glycosides, alkaloids, phenols, tannins and saponins and the results were 
recorded. 
1. Test for sterols 
The powder was first extracted with petroleum ether and evaporated to a residue. 
Then the residue was dissolved in chloroform and tested for sterols. 
a. Salkowski’s Test: A few drops of concentrated sulphuric acid were added to the above 
solution, shaken well and set aside. The lower chloroform layer of the solution turning red 
indicates the presence of sterols. 
b. Liebermann – Burchard’s Test: To the chloroform solution a few drops of acetic 
anhydride and 1mL of concentrated sulphuric acid were added through the sides of the test 
tube and set aside for a while. At the junction of two layers a brown ring and the upper layer 
turning green indicates the presence of sterols. 
2. Test for carbohydrates 
a. Benedict’s test: The aqueous extract of the powdered was treated with Benedict’s reagent 
and boiled on water bath and cooled. Orange precipitate indicates the presence of 
carbohydrates. 
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b. Fehling’s Test: The aqueous extract of the powdered leaf was treated with Fehling’s 
solution I and II and heated on a boiling water bath for half an hour.  A red precipitate 
indicates the presence of free reducing sugars 
3. Test for glycosides  
The substance was mixed with a little anthrone on a watch glass. One drop of 
concentrated sulphuric acid was added, made into a paste and warmed gently over a water 
bath. No dark green coloration indicates the absence of glycosides. 
4. Test for Cardiac Glycosides 
a. Keller Kiliani Test: The substance was boiled with 10% alcohol for 2min, cooled 
and filtered. To the filtrate, lead sub acetate was added and filtered. The filtrate was then 
extracted with chloroform. The chloroform layer was separated and evaporated to dryness. 
The residue was dissolved in glacial acetic acid with traces of ferric chloride. To this few 
drops of sulphuric acid was added slowly along the sides of the test tube. No reddish brown 
layer changes to green colour on standing indicate the absence of cardiac glycosides.  
b. Legal test: The substance was dissolved in pyridine; sodium  nitroprusside solution 
was added to it and made alkaline. No pink or red colour indicates the absence of cardiac 
glycosides. 
c. Baljet test: To the substance sodium picrate solution is added. No yellow to orange 
colour indicates the absence of cardiac glycosides. 
4.  Test for Proteins and free amino acids 
a. Millon’s Test: A small quantity of aciduous – alcoholic extract of the powdered 
drug was heated with Millon’s reagent. White precipitate indicates the presence of proteins.  
b. Biuret Test: To the alcoholic extract of powdered drug, one ml of dilute sodium 
hydroxide(10%) solution was added followed by this one drop of very dilute copper sulphate 
solution was added.  No Violet colour  indicates  the absence of proteins. 
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5. Test for Mucilage 
A few mL of aqueous extract was prepared from the powdered drug was treated with 
ruthenium red.  No Pinkish red colour indicates the absence of mucilage. 
6. Test for Flavonoids 
a. Magnesium turning- con HCl test:  A little of the powdered drug was heated with 
alcohol and filtered. To the test solution magnesium turnings and few drops of concentrated 
hydrochloric acid were added and Boiled for five minutes. A red colour indicates the 
presence of flavonoids. 
b. Alkali Test: To the small quantity of test solution 10% aqueous sodium hydroxide 
Solution was added. A yellow orange color indicates the presence of flavonoids.  
7. Test for terpenoids 
The powdered leaf was shaken with petroleum ether and filtered. The filtrate was 
evaporated and residue obtained was dissolved in small amount of chloroform and the 
chloroform solution tin and thionyl chloride were added. A pink color indicates the presence 
of terpenoids. 
8. Test for Tannins  
A small quantity of the powdered drug was extracted with water. To the aqueous 
extract, few drops of ferric chloride solution were added. A bluish black color indicates the 
presence of tannins. 
10. Test for Alkaloid 
About 2g of the powdered material was mixed with 1g of calcium hydroxide and 5mL 
of water into a smooth paste and set aside for 5min. It was then evaporated to dryness in a 
porcelain dish on a water bath. To the residue, 20mL of chloroform was added, mixed well 
and refluxed for half an hour on a water bath. Then it was filtered and the chloroform was 
evaporated. To the residue, 5mL of dilute hydrochloric acid was added. The solution was 
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divided into four parts and 2mL of each of the following reagents were added and the colour 
noted below indicates the presence of alkaloids. 
a) Mayer’s Reagent  - Cream precipitate  
b) Dragendorff’s Reagent - Reddish brown precipitate  
c) Hager’s Reagent   -  Yellow precipitate 
d) Wagner’s Reagent   - Reddish brown precipitate 
Test for purine group (Murexide test) 
The residue obtained after the evaporation of chloroform as described above was 
treated with 1mL of hydrochloric acid in a porcelain dish and 0.1gm of potassium chlorate 
was added and evaporated to dryness on water bath. Then the residue was exposed to the 
vapour of dilute ammonia solution. Purple colour indicates the presence of purine group of 
alkaloids. 
Test for carbazole alkaloids 
To the alcoholic extract of the leaf powder, conc. H2SO4 was added.  No Violet color 
indicates absence of carbazole alkaloids.  
10.  Test for saponins 
Foam test:  About 0.5g of the powdered drug was boiled gently for 2min with 20mL of water 
and filtered while hot and allowed to cool. 5mL of the filtrate was then diluted with water and 
shaken vigorously.  Frothing indicates the presence of saponins. 
The above chemical tests were carried out using whole plant ethanolic extract of 
Andrographis echioides (L.) Nees and the results were tabulated in Table 5.   
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SECTION B - QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENT [83-89] 
The quantitative estimation of therapeutically active phytoconstituents in medicinal 
plant is very essential for their identification and quantification.  A particular group of 
compound like flavanoids, polyphenols, tannin and alkaloids are the widest spread secondary 
metabolites in plant kingdom. These compounds have received much attention as potential 
natural therapeutic properties. Therfore, it is worthwhile to determine the total amount of 
flavonoid ,tannin and vitamin c   present in the crude extracts can be quantified by means of 
using standard procedure with reference marker compound and then reporting them as 
equivalent to that much amount of compound present in that extract as per standard 
compound.  
1. Determination of total phenolic content [83] 
Principle 
 The total phenol content of Andrographis  echioides (L) Nees., was determined by the 
Folin-Ciocalteu colorimetric method. The Folin Ciocalteu reagent is a mixture of 
phosphomolybdate and phosphotungstate. The method measures the amount of substance 
needed to inhibit the oxidation of the reagent.  
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
 10% sodium carbonate 
 1N Folin-Ciocalteu reagent (diluted with equal volume of water and made 1N) 
Procedure  
  The compound gallic acid was used as standard and was weighed and dissolved in 
distilled water to produce 1mg/mL stock solution. The stock solution was further diluted to 
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get concentrations ranging from 2-10µg/mL. To these solutions, 0.5mL of Folin-Ciocalteu 
reagent and 0.5mL of sodium carbonate was added and the final volume was made up to 
10mL with distilled water. The absorbance was measured at 760nm after incubation at room 
temperature for 30min. The 70% ethanolic extract (0.5mL of 50µg/mL and 1mL of 
100µg/mL) was mixed with 0.5mL of Folin-Ciocalteu reagent and 0.5mL of 10℅ sodium 
carbonate and final volume was made up to 10mL with distilled water, and the absorbance 
was measured at 760nm after incubation at room temperature for 30min. A calibration curve 
was constructed by plotting concentration versus absorbance of gallic acid (Fig 10.). A linear 
regression equation was formed and the amount of phenolic compounds was determined 
using this equation.  The total phenolic content was expressed as mg gallic acid equivalents 
(GAE)/g of extract. The results are tabulated in Table 6. 
Determination of total flavanoid content [84-86] 
Principle 
The aluminum chloride colorimetric technique was used for estimation of total 
flavonoid estimation.[85. Aluminum ions form stable complexes with C4 keto group and either 
to C3 or C5 hydroxyl groups of flavones and flavonols in acidic medium. It also forms acid 
labile complexes with ortho hydroxyl groups in the A or B rings of flavanoids. These 
complexes showed a strong absorption at 415nm which is used for the estimation of 
flavanoids.  
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
10% aluminium chloride 
1M potassium acetate 
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Procedure  
A known quantity of quercetin was dissolved in ethanol to get a stock solution of 
1mg/mL. Further dilutions were made to get concentrations ranging from 20-100µg/mL. 1ml 
of the above standard solutions were taken in different volumetric flasks, 0.1mL of 
aluminium chloride solution, 0.1mL of potassium acetate solution and 2.8mL of ethanol were 
added and the final volume was then made up to 5mL with distilled water. After 20min the 
absorbance was measured at 415nm. A sample without aluminium chloride was used as a 
blank. From the absorbance obtained, a calibration curve was constructed by plotting 
concentration versus absorbance of quercetin (Fig.11). 1mL of ethanolic extract at 
concentrations 50µg/mL and 100µg/mL were taken and the reaction was carried out as above 
and the absorbance was measured at 415nm after 20min and the readings were tabulated in 
Table 7. The amount of flavonoids present can be determined by linear regression analysis. 
The total flavonoid content was expressed as mg querecetin equivalents /g of extract.  
3. Determination of total tannin content [88, 89] 
Principle 
 Total tannin content of ethanolic extracts Andrographis echioides (L) Nees was 
determined by Folin Denis reagent method. Tannin like compounds reduces 
phosphotungstomolybdic acid in alkaline solution to produce a highly blue coloured solution. 
The intensity is measured in a spectrometerically at 700nm 
Reagents 
a) Folin Denis Reagent ( sodium tungstate 100g and phosphomolybdic acid 20gm 
were dissolved in distilled water 750ml along with phosphoric acid 50ml. The 
mixture was refluxed for 2 hr and volume was made up to 1 litre with distilled 
water )  
b) Sodium carbonates solution (10%) 
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Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Procedure 
An aliquot of 0.2ml and0.4ml of (1mg/ml) ethanolic extracts of Andrographis echioides 
(L)Nees was taken in separate test tubes and mixed with distilled water to made up to the 
volume of 1ml. Then add 0.5ml of Folin Denis reagent and allowed to stand for 15 mins, then 
1ml of 10% sodium carbonate solution was added and the mixture was mixed with distilled 
water and made up to 10ml, allowed to stand for 30min at room temperature and the tannin 
content was determined spectrophotometrically at 700nm and the readings were tabulated in     
Table 8. 
The calibration curve was generated by preparing tannic acid at different 
concentration (2 -10µg/mL) (Fig 12). The reaction mixture without sample was used as 
blank. The total tannin content in the ethanolic extract of was expressed as milligrams of 
tannic acid equivalent per gm of extract. 
Estimation of vitamin C [87] 
Principle 
The estimation of Vitamin C was carried out using the method of Subasini et al., with 
slight modifications. The keto group of ascorbic acid undergoes a condensation reaction with 
2, 4 dinitro phenyl hydrazine to form a hydrazone which is orange yellow and has an 
absorbance of about 520nm. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
0.2% dinitro phenyl hydrazine  
85% sulphuric acid 
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Procedure  
Ascorbic acid was weighed and dissolved in water to get stock solution of 1mg/mL. 
Further dilutions were made to get the concentrations ranging from 40-200µg/mL. To 1mL of 
sample 0.5mL of dinitro phenyl hydrazine solution was added and incubated for 3h at 37ºC. 
After 3h, 2.5mL of 85% sulphuric acid was added and the absorbance was measured after 
30min at 520nm. A calibration curve was constructed by plotting concentration versus 
absorbance of ascorbic acid (Fig 13). The procedure was repeated for the plant extract (200 
µg/mL.) as above and the absorbance was measured at 520nm after 3h and the readings were 
tabulated in Table 9. The amount of vitamin C present can be determined by linear regression 
analysis. The vitamin C content was expressed as mg/g of extract. 
SECTION C - DETERMINATION OF METALS AND MINERALS BY X-RAY 
FLUORIMETRY [90] 
The herbal products or extracts can have high level of heavy metals and 
elements.Which shows the need to study their level in important medicinal plants.  In ancient 
days, Indian medicinal system recommended most of the herbal drugs in the form of 
decoction (hot water extract), where the possibility of heavy metal toxicity is minimized or 
detoxified by other medicinal plants. It has been reported that whatever is taken as food could 
cause metabolic disturbance subject to the allowed upper& lower limits of trace metals. The 
deficiency & excess of essential micronutrients & trace toxic metals can cause serious effects 
on health. Some metals are also essential nutrients (Cu, Fe, Zn etc.) & only become toxic at 
higher concentrations, while others (Pb, Cd, Ni etc.) don’t have beneficial properties.  
X-ray fluorescence (XRF) analysis is one of the most common non-destructive 
methods for qualitative as well as quantitative determination of elemental composition of 
materials. It is suitable for solids, liquids as well as powders. There are two main 
methodological techniques that are wavelength dispersive analysis (WD-XRF) and energy 
dispersive analysis (EDXRF) where the spectra are collected simultaneously in a wide energy 
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range. XRF has the advantage of being non-destructive, multi-elemental, fast and cost-
effective. Furthermore, it offers a fairly uniform detection limit across a large portion of the 
Periodic Table and is applicable to a wide range of concentrations from 100% to a few ppm.  
Principle 
X-ray is a type of electromagnetic waves such as visible light ray, but the difference is 
its extremely short wavelength, measuring from 100A to 0.1A. X-ray fluorescence analysis is 
a method that uses the characteristic X-ray (fluorescent X-ray) that is generated when X-ray 
is irradiated on a substance. The fluorescent X-ray is the excess energy irradiated as 
electromagnetic field, which is generated when the irradiated X-ray forces the constituent 
atom's inner-shell electrons to the outer shell and the vacant space (acceptor) falls on the 
outer-shell electrons. The generation of fluorescent X-ray. These rays possess energy 
characteristic to each element, and qualitative analysis and quantitative analysis using the 
energy's X-ray intensity (number of photons) are possible. X-ray fluorescence analysis can be 
considered as spectrochemical analysis of an X-ray region. It has the same characteristics as 
atomic absorption 
For example, in flameless atomic absorption spectrometry (FLAAS), elements in the sample 
are atomized in 2000 to 3000C flame and in ICP atomic emission spectrometry (ICP-AES), 
sample is excited in 6000 to 9000C plasma flame. X-ray fluorescence likewise excites the 
sample using X-ray to obtain information. 
Fig. 14   X-ray generation 
 
 
 
Instrument  
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Instrument   :  Bruker S4-Pioneer 
Standard Anode material  :  Rhodium 
Detector    :  Scintillation counter and proportional counter 
Software   :  SPECTRA plus software 
Version    :  1.6 
Sample preparation (Pressed pellet technique) 
The sample used for XRF analysis was prepared as a flat disc (pellet), with a diameter 
of 20-50nm.  The pellet was made with the sample powder in the ratio of 1:4, i.e., 2mg of 
whole plant of Andrographis echioides powder was mixed with 8mg of diluents like boric 
acid or stearates (calcium.magnesium). The pellet looked like a bilayer tablet which consists 
of drug one side and diluents on the other side. 
Procedure 
The sample pellet was then subjected to X-ray fluorimetric analysis for the period of 1 
hr approximately.  The elements which were present in the sample were analysed and the 
results were interpreted automatically by the software package of the computer in terms of 
parts per million. The results obtained are presented in Table 10. 
SECTION D - CHROMATOGRAPHY 
Herbal drugs are accepted as important therapeutic agents for the treatment of many 
diseases. The development of authentic analytical methods which can reliably profile the 
phytochemical composition, including quantitative analyses of marker/bioactive compounds 
and other major constituents, is a major challenge to scientists. Pharmacognostical analysis of 
medicinal herbs remains challenging issues for analytical chemists, as herbs are a 
complicated system of mixtures. Analytical separation techniques for example 
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chromatography , and mass spectrometry (MS),  etc. among the most popular methods of 
choice used for quality control of raw material and finished herbal product.[91,92] 
Chromatography represents the most versatile separation technique and readily 
available. Plant materials are separated and purified by using various chromatographic 
techniques. Herbal medicine is a complicated system of mixtures. Thus, the methods of 
choice for identification of “botanical drug” are mainly intended to obtain a characteristic 
fingerprint of a specific plant that represent the presence of a particular quality defining 
chemical constituents. For such purposes, chromatographic techniques such as high 
performance liquid chromatography (HPLC), gas chromatography (GC), gas chromatography 
– mass spectrometry (GC-MS) and thin layer chromatography (TLC) were used widely as 
reported in numerous publications. 
Chromatography is the separation of two or more compounds or ions from mixture of 
compounds by the equilibrium distribution between two phases, one which is moving and the 
other which is stationary. These two phases can be solid-liquid, liquid-liquid or gas-liquid. 
THIN LAYER CHROMATOGRAPHY 
Principle  
The principle of separation is adsorption. The components move according to their 
affinities towards the adsorbent. The component with more affinity towards the stationary 
phase travel slower and the components with less affinity towards the stationary phase travel 
faster. Thus the components are separated on a thin layer chromatographic plate based on the 
affinity of the components towards the stationary phase. 
Preparation of TLC Plates 
Slurry of the adsorbent (silica gel G) was prepared in water (1: 2).  Dry, clean glass 
plates (20cm x 5cm) were laid in a row as a template, the suspension was poured into Stahl 
TLC spreader, which was adjusted to 0.25mm thickness and coated in a single passage of the 
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spreader over them. These plates were left on the template for air drying until the 
transparency of the layer disappeared and dried at 110oC for 30min and kept in a dessicator. 
The plates were used when required.  Aluminum plates coated with silica gel G F254 (Merck) 
were also used.  
Application of Extract 
Adrographis echioides extract was mixed with methanol and taken in a capillary tube 
and it was banded on TLC plate 2cm above the bottom end. 
Development of chromatogram 
TLC plates were developed in a chromatographic tank by using the mobile phase 
Toluene: Ethyl acetate: Methanol (5:3:2). The plates were allowed to develop 3/4 of the 
length and then removed. The solvent front was immediately marked and the plates were 
allowed to dry and then it was examined by visually, under UV light at 254 and 366nm. The 
results are presented in table 11. 
Stationary phase -   Silica Gel G 
 Mobile phase   -   Toluene: Ethyl acetate: Methanol (5: 3: 2) 
Detecting agent - Visual & UV light  
The TLC plates were examined and the spots were viewed under UV light and in day 
light. The Rf value of the spots obtained were calculated using the formula - [Distance 
travelled by solute / Distance travelled by solvent]. The photographic representation of the 
plate under UV light and in day light is presented in Fig 15 and the Rf value of the spots are 
presented in the table 11. 
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY [93-94] 
 HPTLC method is advanced method of Thin Layer chromatography (TLC). It has 
more advantages like better resolution, faster development of spots and also easy detection 
and quantification of separated compounds over TLC. HPTLC is useful method for 
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identification of plants and extracts. It is used as a powerful quality control tool when the 
similarities and differences between the test samples and the standard markers are compared. 
HPTLC is the most reliable method for quantification of phytoconstituents even present in 
nanogram level. This finger print analysis can be used to check and monitor the purity of 
drugs rapidely. It can also be used for the detection of adulterants.  
Isolation of Andrographolide [26] 
200g of whole dried crushed Andrographis echioides was extracted, twice with a 1:1 
mixture of dichloromethane and methanol by cold maceration (1 × 1L and 1 × 0.2L). Each 
extraction was conducted for 6h with constant stirring. The extracts were filtered and the 
filtrates were concentrated at a temperature below 70°C to produce a green mass. The green 
mass was washed with toluene several times until most of coloured matter was removed from 
the residue. The toluene was completely removed from the residue by evaporation. The 
residue was dissolved in 60-70°C hot ethanol and filtered while hot. The filtrate was cooled 
in a refrigerator for crystallization. 
Instrument  
CAMAG TLC Scanner 3 "Scanner3-070408"S/N 070408(1.41.21) was used for 
detection and CAMAG Linomat 5 sample applicator was used for the application of the track. 
Twin trough plate development chamber was used for development of chromatogram. 
Software used was winCATS 1.4.3 
Sample 
The Andrographis echioides was dissolved in 1ml of methanol and 2μL of this 
solution was used for taking HPTLC fingerprint.  
Stationary Phase 
Aluminium sheets pre-coated with silica gel Merck G F254, 0.2mm layer thickness 
were used as the stationary phase.  
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Mobile phase 
Toluene: ethyl acetate: methanol (5: 3: 2) was used as the mobile phase for 
development of chromatogram. The mobile phase was taken in a CAMAG twin trough glass 
chamber. 
Detection wavelength 
The developed plates were examined at wavelength 254nm and 366nm in 
Densitometry TLC scanner3. The TLC visualization, 3D display of the finger print profile 
and peak display at 254nm and 366nm are presented in Fig 16 to 19.   The Rf values and area 
under curve for each peak of are presented in Table 12.  
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RESULTS AND DISCUSSION 
SECTION A - PRELIMINARY PHYTOCHEMICAL SCREENING  
 The results obtained for the preliminary phytochemical screening is depicted in  
Table 5.  
Table 5: Preliminary phytochemical screening for the 70% ethanolic  
extract of Andrographis echioides (L.)Nees   
 
S. No. TEST RESULTS 
1. TEST FOR STEROLS  
 a. Salkowski’s test + 
 b. Libermann- burchard’s test + 
2. TEST FOR CARBOHYDRATES  
 a. Molisch’s test + 
 b. Fehling’s test + 
 c. Benedict’s test + 
3. TEST FOR PROTEINS  
 a. Millon’s test _ 
 b. Biuret test _ 
4. TEST FOR ALKALOIDS  
 a. Mayer’s reagent + 
 b. Dragendroff’s reagent + 
 c. Hager’s reagent + 
 d. Wagner’s reagent + 
5. TEST FOR GLYCOSIDES  
 a. Anthraquinone glycosides _ 
     i) Borntrager’s test _ 
     ii) Modified Borntrager’s test _ 
 b. Cardiac glycosides  
     i) Keller Killiani test  - 
6. TEST FOR SAPONINS  
 Foam test + 
7. TEST FOR TANNINS  
 Fecl3 test  + 
8. TEST FOR FLAVONOIDS  
 a. Shinoda test + 
 b. Alkali test + 
 c. Acid test + 
9. TEST FOR TRITERPENOIDS + 
10. TEST FOR VOLATILE OILS - 
  (+) indicates positive reaction (-) indicates negative reaction  
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Calibration curve of gallic acid
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The 70% ethanolic extract of whole plant of Andrographis echioides showed the 
presence of sterols, alkaloids, carbhydrates, Triterpenoids, flavonoids, phenols, tannins and 
saponins.   
SECTION B - QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
 The results obtained for estimation of various phyto constituents are discussed in this 
section.  
Estimation of total phenol content  
 The results for the total phenolic content of 70% ethanolic extract of Andrographis 
echioides (L.)Nees were tabulated in table 6 and the calibration curve for standard gallic acid 
is represented in Fig 10.  
Table 6: Total phenolic content in 70% ethanolic  
extract of in terms of gallic acid equivalents 
S. 
No. 
Conc. of 
gallic 
acid in 
µg/mL 
Absorbance at 
760nm 
Conc. of 
ethanol 
extract in 
µg/mL 
Absorbance 
at 760nm* 
Amt. of  phenolic 
content in terms mg 
GAE/g of ext.* 
1 2 0.229 ± 0.010 50 0.22 ± 0.002 39.84 ± 0.35 
2 4 0.452 ± 0.006 100 0.48 ± 0.001 43.10 ± 0.95 
3 6 0.695 ± 0.005  
Average 41.47±0.65 4 8 0.918 ± 0.031  
5 10 1.162 ± 0.028  
* mean of three readings ±SEM 
Fig 10.  Calibration curve of gallic acid 
 
 
 
 
Chapter VI                                                                   Phytochemical Studies 
Department of Pharmacognosy, MMC.                                                Page 66 
Calibration curve of quercetin
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 The linear regression equation was found to be y = 0.116x - 0.004 while the correlation 
was found to be 0.9998. The amount of phenolic content present in the extract in terms mg 
GAE/g of extract was found to be 41.47±0.65 by using the above linear regression equation. 
Estimation of total flavonoid content 
The results for total flavonoid content of 70% ethanolic extract of Andrographis 
echioides (L) Nees were presented in table 7 and the calibration curve for quercetin is 
presented in Fig 11.  
Table 7: Total flavonoid content per gram of extract in terms of quercetin  
by aluminium chloride method 
S. 
No. 
Conc. of 
quercetin 
in µg/mL 
Absorbance at 
415nm 
Conc. of 
ethanol 
extract in 
µg/Ml 
Absorbance at 
415nm 
Amt of  flavonoid 
content in terms mg 
quercetin 
equivalent/ g of ext. 
1 20 0.589 ± 0.01 50 0.024±0.0006 41.87±0.23 
2 40 1.151 ± 0.04 100 0.116±0.003 53.16±0.01 
3 60 1.710 ± 0.09  
Average 47.515±0.12 4 80 2.390 ± 0.03  
5 100 3.112 ± 0.03  
*mean of three readings ± SEM 
   
Fig 11. Calibration curve of quercetin 
 
 
 
 
 
 
The linear regression equation was found to be y = 0.0307x-0.0432 while the 
correlation was found to be 0.9974. The amount of flavonoid content present in the ethanolic 
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extract of  Andrographis echioides(L)Nees in terms mg quercetin equivalent/g of extract was 
found to be  47.515±0.12mg/g of extract by using the above linear regression equation.    
Estimation of total tannin content 
The results for total tannin content of 70% ethanolic extract of Andrographis 
echioides (L.)Nees are presented in Table 8 and the calibration curve for tannic acid is 
presented in Fig 12.  
Table 8: Total tannin content in 70% ethanolic extract of Andrographis echioides 
(L) Nees of tannic acid equivalents 
 
S. 
No. 
Conc.  of 
tannic acid 
in µg/mL 
Absorbance 
at 415nm 
Conc. of 
ethanolic
extract in 
µg/mL 
Absorbance 
at 415nm 
Amt of total tannic 
acid content in terms 
mg quercetin 
equivalent/ g of extract 
1 2 0.581 ± 0.01 20 0.024 ± 0.001 42.5 ± 0.12 
2 4 1.151 ± 0.04 40 0.065 ± 0.001 63.9 ± 0.09 
3 6 1.710 ± 0.09  
Average 53.2 ± 0.105 4 8 2.390 ± 0.03  
5 10 3.112 ± 0.03  
*mean of three readings ± SEM 
 
Fig 12: Calibration curve for tannic acid 
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The linear regression equation was found to be y = 0.022x + 0.003.while the 
correlation was found to be 0.9997. The amount of tannin content present in the extract in 
terms mg equivalent /g was to be 53.2±0.105 mg/gm of extract by using above linear 
equation. 
Estimation of Vitamic C content 
The results for vitamin C content of 70% ethanolic extract of Andrographis echioides 
are presented in Table 9 and the calibration curve for ascorbic acid is presented in Fig 13.  
Table 9: Estimation of Vitamin C in Andrographis echioides (L) Nees 
*mean of three readings ± SEM 
Fig. 13: Calibration curve of ascorbic acid 
 
 
 
 
 
 
 
 
S. 
No. 
Conc. of 
ascorbic acid 
in µg/mL 
Absorbance at 
520nm 
Conc. of 
methanol 
extract in 
µg/mL 
Absorbance 
at 520nm 
Amt of vitamin 
C present / g of 
extract 
1 40 0.135 ± 0.000 200 0.087±0.0006 222.76±0.370 
2 80 0.265 ± 0.015    
3 120 0.346 ± 0.010    
4 160 0.468 ± 0.011    
5 200 0.525 ± 0.010    
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           The linear regression equation was found to be y = 0.0027x + 0.012 and a correlation 
co-efficient of 0.9982. The amount of vitamin C content present in the 70% ethanolic extract 
of Adrographis echioides was found to be 222.76 ± 0.37 mg/g of fresh leaves by using the 
above  linear regression equation.       
SECTION C - DETERMINATION OF MTALS AND MINERALS BY X-RAY 
FLUORIMETRY 
  
The various elements present in elemental form and in oxide form are presented in table 10.  
Table 10:   Elemental analysis of whole plant powder of  
Andrographis echioides (L) Nees 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oxide form AN-EC Elemental form AN-EC 
Formula Conc % Formula Conc % 
Al2O3 0.178 Al 0.094 
Br 0.037 Br 0.037 
CaO 16.690 Ca 11.930 
Cl 3.389 Cl 3.389 
CuO 0.015 Cu 0.012 
Fe2O3 0.337 Fe 0.236 
K2O 9.650 K 8.011 
MgO 1.716 Mg 1.035 
Na2O 0.169 Na 0.126 
  O 8.870 
P2O5 0.888 P 0.388 
SO3 2.052 S 0.822 
SiO2 1.050 Si 0.493 
SrO 0.182 Sr 0.154 
ZnO 0.022 Zn 0.018 
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SECTION D - CHROMATOGRAPHY 
Thin layer chromatography Andrographis echioides (L.) Nees extract 
The photographic visualization of the TLC plate is represented in Fig 15. 
Fig 15: Thin layer chromatography of Andrographis echioides (L) Nees extract 
  Visible light        UV light@254nm 
 
 
 
 
 
 
 
 
 
 
Table 11: TLC of Andrographis echioides (L) Nees extract 
S. 
No 
Solvent 
system 
Detecting 
agent 
No of 
spots Color of spots
Rf values 
of extract 
Rf values 
of std 
1. 
Toluene: ethyl 
acetate : 
methanol  
(5: 3: 2) 
Visible 
light 
8 
Light brown 0.29 
 
Brown 0.52 
Dark brown 0.57 
Yellow 0.61 
Light yellow 0.68 
Orange 0.80 
Light brown 0.84 
Brown 0.89 
Under UV 
light at 
254nm 
3 
Light green 0.38 
0.57 Green 0.57 
Light green 0.65 
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The extract when viewed in day light showed 8 spots  at Rf value of 0.29, 0.52, 0.57, 
0.61, 0.68, 0.80, 0.84 and 0.89 and when viewed under visible light, 3 spots at Rf value of  
0.38, 0.57 and 0.65 after development in the mobile phase namely Toluene: Ethyl acetate: 
Methanol(5:3:2) were seen. 
 The Rf value obtained for the extract was also compared with a standard 
Andrographolide. The Rf value of the extract at 0.57 matched with that of the standard and 
hence andrographolide may be present in the extract. Further confirmation must be done 
using HPTLC.  
High Performance Thin Layer Chromatography 
The visualization of the TLC plate of Andrographis echioides extract at 254nm and 
366nm is presented in Fig 16.  The photo of plate at 254nm shows the presence of 8 spots in 
extract and 1 spot in standard, while at 366nm shows the presence 6 spots. 
Fig 16:  Visualization at 254nm and 366nm 
             @254nm                                                            366nm 
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The 3D display of the fingerprint profile and the peak display of Andrographis 
echioides (L) Nees and standard andrographolide at 254nm and 366nm is presented in Figs 
17, 18 & 19.  
Fig 17:  3D Display of the fingerprint profile at 254nm and 366nm 
@ 254nm                                                        @ 366nm 
 
Fig 18. Overlay Spectral Display 
 
The display at 254nm shows the presence of 8 peaks and standard shows the presence 
of 1 peak while at 366nm shows the presence of 6 peaks for the sample and no peaks for 
standard. The Rf values of peaks along with the area under the curve for each peak at 254 and 
366 nm are tabulated in Table 12. 
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Fig 19: Peak display of standard Andrographolide and 
Andrographis echioides extract at 254nm and 366nm 
 
Peak Display @ 254nm 
                                STD     Extract 
                
 
Peak Display @ 366nm 
  STD      Extract 
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Table 12: Rf values and area under the curve for each peak at 254 and 366nm 
 
S.No 
@ 254nm @ 366nm 
STD Sample STD Sample 
 
Rf 
value 
Area  
(AU) 
Rf 
value
Area  
(AU) 
Rf 
value 
Area  
(AU) 
Rf 
value 
Area  
(AU) 
1 0.54  5050.2  0.15  236.8    0.21  6806.9  
2   0.23  1052.3    0.30  26810.8 
3   0.31  11527.8   0.43  10707.2 
4   0.39  10950.3   0.51  14427.3 
5   0.48  12872.3   0.57  4704.4  
6   0.56  10315.1   0.61  19172.9 
7   0.65  1099.7      
8   0.77  3001.7      
 
         From the table 12, it can be seen that the Rf value of spot number 5 of the sample 
coincided with that of the standard andrographolide and hence may be concluded that 
andrographolide is present in the sample. Isolation and characterization has to be carried out 
in future.   
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CHAPTER-7 
PHARMACOLOGICAL STUDIES 
The ethanolic extract of Andrographis echioides was subjected to pharmacological 
screening and the following activities were carried out namely in vitro antioxidant activity, in 
vitro anti lithiatic, in vitro anti diabetic, antibacterial and antifungal activities. 
SECTION A - IN VITRO ANTIOXIDANT ACTIVITY 
An antioxidant is a molecule capable of slowing or preventing the oxidation of other 
molecules. Oxidation is a chemical reaction that transfersan electron from a substance to an 
oxidizing agent. Oxidation reaction can produce free radicals which start chain reactions that 
damage cells. Antioxidants terminate these chain reactions by removing free radical 
intermediates and inhibit other oxidation reaction by being oxidized themselves.The cellular 
anti-oxidant status determines the susceptibility to oxidative damage and usually altered 
inresponse to oxidative stress. [96] 
The role of antioxidants are protecting against certain conditions such as heart 
disease, stroke and cancer, anemia, Parkinson’s diseases, mongolism, neuro degeneration. It 
has been proposed that the mechanisms leading to these diseases may be promoted by free 
radicals and that antioxidants may oppose the action of these molecules. In addition to the 
well  known antioxidants such as Vitamins C and E, there is growing research demonstrating 
the potentially beneficial effects of plant-derived antioxidants,polyphenols, found in fruits, 
vegetables, nuts, cereals and drinks such as tea and red wine. 
Free radicals  
Free radicals are unstable molecules that include the hydrogen atom, nitric oxide(NO) 
and molecular oxygen (O2). These naturally occur in the body as a result ofchemical reactions 
during normal cellular processes. They can also be formed inresponse to excess pollution, too 
much UV sunlight and exposure to cigarettesmoke. In an attempt to stabilize, they attack other 
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molecules in the body potentially leading to cell damage and triggering the formation of 
another free radical resulting in a chain reaction. This type of free radical action has been 
implicated in certain chronic and aging diseases such as cancer, heart disease, stroke, 
rheumatoid arthritis, cataracts and Alzheimer’s disease. 
Protective mechanisms of antioxidants 
Antioxidants are compounds that help to inhibit the many oxidation reactions caused 
by free radicals thereby preventing or delaying damage to the cells and tissues. Their 
mechanisms of action include:- 
 Scavenging reactive oxygen and nitrogen free radical species. 
 Decreasing the localised oxygen concentration thereby reducing molecular 
oxygen’s oxidation potential. 
 Metabolising lipid peroxides to non-radical products. 
 Chelating metal ions to prevent the generation of free radicals. 
Types of antioxidants 
Synthetic antioxidants: 
Butylated hydroxyl toluene (BHT), butylated hydroxyl anisole(BHA), tertiary 
butylated hydroxyl quinine and gallic acid ester. 
Plant derived antioxidants: 
 Tannins, lignans, stilbens, coumarins, quinones, xanthones, phenolic acids, flavones, 
flavonols, catechin, anthocyanins and proanthocyanins prevent the onset of degenerative 
diseases because of their redox properties which allow them to act as hydrogen donors, 
reducing agents, hydroxyl radical scavengers and nitric oxide scavengers. 
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Methods for screening antioxidant activity 
Some of the in vitro models for the evaluation of antioxidant activity are enumerated below  
 DPPH method 
 Hydrogen peroxide method 
 Superoxide radical scavenging activity 
 Hydroxyl radical scavenging activity 
 Nitric oxide radical inhibition assay 
 Reducing power assay 
 Phosphomolybdenum method 
 Peroxy nitrile radical scavenging activity 
 Xanthine oxidase method 
 Ferric reducing ability of Plasma 
 Thiobarbituric acid assay etc. 
Method 1: Free radical Scavenging activity using diphenylpicrylhydrazyl (DPPH) free 
radical[95-97] 
Principle 
The free radical scavenging activity of the extracts is evaluated by assessing their 
ability to reduce the colour of DPPH in ethanol according to Jananie et al., 2011. DPPH 
stable free radical method is an easy, rapid and sensitive way to survey the antioxidant 
activity of specific compound or plant extracts. DPPH is a stable free radical with a 
distinctive ESR signal. Its reaction with antioxidants can be followed by the loss of 
absorbance at 518nm. It is widely accepted that DPPH accept an electron or hydrogen radical 
and become a stable diamagnetic molecule. Due to its odd electron, the ethanol solution of 
DPPH (purple colour solution) shows a strong absorption at 517nm. DPPH radicals react with 
suitable reducing agents where the pairing of electrons takes place and the solution loses 
colour stochiometrically with the number of electrons taken up. 
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DPPH. + AH   DPPH – H + A. 
Instrument 
Shimadzu UV Visible spectrometer, Model 1800 
Reagents 
0.1mMdiphenylpicrylhydrazylradical in ethanol 
Procedure 
A stock solution of 1mg/mL concentration of 70% ethanolic extract of Andrographis 
echioides was prepared. To 1mL of various concentrations of test sample, 4mL of DPPH was 
added. Control was prepared without sample in an identical manner. DPPH was replaced by 
ethanol in case of control. The reaction was allowed to be completed in the dark for about 
30min. Then the absorbance was measured at 517nm. Vitamin C was used as standard. The 
percentage scavenging was calculated using the formula [(Control-Test)/Control] x 100. A 
graph was constructed by plotting concentration versus percentage inhibition (Fig. 24) and a 
linear regression equation calculated. The concentration of the sample required for 50% 
reduction in absorbance (IC50) was calculated using linear regression analysis.  A triplicate 
reading was taken and average was calculated.  The results obtained are presented in table 
13. 
Method 2: Determination of scavenging activity against hydrogen peroxide [98, 99] 
Principle  
The free radical scavenging activity of plant extract against hydrogen peroxide was 
determined by using the method of Janani et al, 2011. The principle was based on the 
capacity of the extracts to decompose the hydrogen peroxide to water.H2O2  in the presence 
of O2-can generate highly reactive .OH hydroxyl radicals via the metal, the scavenging of 
H2O2 in cells is critical to avoid oxidative damage.  Thus the scavenging of hydrogen 
peroxide is an important antioxidant defence mechanism. 
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Fe2+ +H2O2 →   Fe3+ + OH + OH- 
The decomposition of hydrogen peroxide to water involves the transfer of electrons  
H2O2 + 2H+ + 2e-→   2H2O 
Instrument 
Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
6% hydrogen peroxide diluted with water in the ratio of 1:10 
0.1M phosphate buffer pH 7.4 
Procedure 
  To the 70% ethanolic extract of Andrographis echioides dissolved in ethanol 
to get a stock solution containing 1mg/mL. Varying quantities of the stock solution were 
added to 3.8mL of 0.1M phosphate buffer solution (pH 7.4) and then 0.2mL of hydrogen 
peroxide solution was added and the absorbance was measured at 230nm after 10min. The 
reaction mixture without sample and reagent was used as blank. The hydrogen peroxide 
solution was used a control. Ascorbic acid was used as standard. The percentage inhibition of 
hydrogen peroxide was calculated using the formula   =   (A control - Asample) / Acontrol  x 100.  A 
graph was plotted using concentration versus percentage inhibition (Fig. 25). A linear 
regression equation was calculated using the above graph. The concentration of extract to 
produce 50% inhibition was found using linear regression analysis.  The results obtained are 
presented in table 14. 
Method 3: Ferric Reducing Antioxidant Power (FRAP) Assay][100] 
Total antioxidant activity is measured by FRAP assay of Benzie et al., 1999. The 
ferric reducing antioxidant power assay measures the potential of antioxidants to reduce the 
Fe3+ and 2,4,6 tripyridyl-s-triazyne (TPTZ) complex present in stoichiometric excess to the 
blue coloured Fe2+ complex which increases the absorption at 593nm. 
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Principle  
At low pH, reduction of ferric tripyridyltriazine (Fe III TPTZ) complex to ferrous 
form (which has an intense blue colour) can be monitored by measuring the change in 
absorption at 593nm. The reaction is non-specific, in that any half reaction that has lower 
redox potential, under reaction conditions, than that of ferric ferrous half reaction, will drive 
the ferrous (Fe III to Fe II) ion formation. The change in absorbance is therefore, directly 
related to the combined or “total” reducing power of the electron donating antioxidants 
present in the reaction mixture. 
Instrument 
Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
FRAP Reagent  
a) Acetate buffer 30mM pH 3.6: Weigh 3.1g sodium acetate trihydrate and add 16 ml 
of glacial acetic acid and make the volume to 1 L with distilled water. 
 b)  TPTZ (2, 4, 6-tripyridyl-s- triazine) (M.W. 312.34) 10mM in 40mM HCl 
c)  FeCl3. 6H2O (M.W. 270.30) 20mM 
The working FRAP reagent was prepared freshly by mixing a b & c in the ratio of    
10:1:1 at the time of use.  
Procedure  
A stock solution of 1mg/mL concentration of ethanolic extract of Andrographis 
echioides was prepared. To the 1mL of various concentrations of test samples and mixed with 
3mL of working FRAP reagent and absorbance was measured at 0min after vortexing at 
593nm. Thereafter samples were placed at 37ºC in water bath and absorption was again 
measured after 4min. Ascorbic acid was used as standard. The FRAP value of the sample was 
calculated using this equation:[Change in absorbance of sample from 0-4min/ change in 
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absorbance of standard from 0-4min] * Frap value of standard.The result obtained for the 
FRAP assay are presented in the Table 15 and Fig. 26. 
Method 4: Reducing power assay [101] 
Principle 
Reducing power assay is a spectrophotometric method and is based on the principle 
that increases in absorbance of the reaction mixture indicates the increases in the reducing 
power of the sample. Anti -oxidant activity may be due to a variety of mechanism viz., the 
prevention of chain initiation, the binding of transition metal ion catalysts, decomposition of 
peroxides, the reductive capacity and free radical scavenging. The assay is based on the 
reduction of ferric in potassium ferricyanide to ferrous to form potassium ferrocyanide by the 
sample and the subsequent formation of Prussian blue colour with ferric chloride. The 
absorbance of the blue complex is measured at 700nm.  
Antioxidant 
Pot. ferricyanide + Ferric chloride →Pot. ferrocyanide + Ferrous chloride 
Instrument 
Shimadzu UV Visible spectrophotometer, Model 1800 
Materials required 
Ethanolic extracts of Andrographis echioides 
1% w/v potassium ferricyanide 
10% w/v trichloro acetic acid   
0.2M, phosphate buffer (pH 6.6) 
0.1% w/v ferric chloride 
Procedure 
The reducing power ability of plant extracts was screened as mentioned by Oyaizu 
et.al., 1986 by assessing the ability of the test extract to reduce FeCl3solution). 0.2 to1 mL of 
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plant extract solution (1mg/mL) was mixed with 0.75mL phosphate buffer and 0.75mL of 1%   
potassium ferricyanide [K3Fe(CN6)] and incubated at 50oC for 20min.0.75mL of 1%trichloro 
acetic acid was added to the mixture ,allowed to stand for 10min. The whole mixture was 
then centrifuged at 3000rpm for 10min. Finally 1.5mL of the supernatant was removed and 
mixed with 1.5mL of distilled water and 0.1mL of 0.1%ferric chloride solution and the 
absorbance measured at 700nm in UV-Visible Spectrophotometer. Ascorbic acid was used as 
standard and phosphate buffer used as blank solution. The results obtained are presented in 
table 16 and Fig. 27. 
Method 5: Total antioxidant activity by Phosphomolybdenum Method [102-104] 
Principle 
 Total antioxidant capacity was measured by spectrophotometric method of Nilgum et 
al., 2009.  Phosphomolybdenum method assay is based on the reduction of Mo (VI) to Mo 
(V) by the sample analyte and the subsequent formation of green phosphate Mo (V) complex 
at acidic pH and the absorbance was measured at 695nm. This method is used to determine 
the total antioxidant activity of samples. 
Mo6+         →        Mo5+ 
Instruments 
Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
0.6M sulphuric acid 
28mM sodium phosphate 
4mM   ammonium molybdate 
Procedure 
An aliquot of 0.3mL of different concentrations of sample solutions was combined 
with 2.7mL of the reagent solution (H2SO4, sodium phosphate and ammonium molybdate). In 
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case of blank, 0.3mL of ethanol was used in place of sample. The tubes were incubated for 
95°C for 90min. After the mixture was cooled to room temperature, the absorbance was 
measured at 695nm against blank. The standard ascorbic acid was treated in a similar manner. 
The total antioxidant activity is expressed as the number of equivalents of ascorbic acid. The 
results obtained are presented in Table 17 and Fig. 28. 
 
SECTION B - INVITRO CALCIUM OXALATE CRYSTALLIZATION INHIBITION  
 
 Kidney stones are one of the painful, common disorders of the urinary tract. Men tend 
to be affected more frequently than women. Urinary stones are polycrystalline aggregate 
consisting varying amount of crystals are formed from dissolved urinary minerals.  Kidney 
stones contain calcium, oxalate, phosphate, magnesium, uric acid.[105] 
The formation of urinary calculi involves a crystallization process that includes nucleation, 
growth and aggregation of crystals.  
Nucleation: Nucleation is the formation of a solid crystal phase in a solution. It is an 
essential step in stone formation.   
Homogeneous nucleation: The term super saturation refers to a solution that contains more 
of the dissolved material than could be dissolved by the solvent under normal circumstances.  
The point at which saturation of a solution is reached, and crystallization begins is commonly 
known as thermodynamic solubility product. Urine contains inhibitors of crystallization and 
can hold large concentrations of solute above the metastable state. If the concentration of 
solute increases further and a point is reached where it cannot be held in solution, which is 
the point of formation of product in urine. The process of nucleation in a pure solution is 
known as homogeneous nucleation   
Heterogeneous nucleation: New crystals deposits on pre-existing crystal surface of similar 
type. Secondary nucleation results in the mass production of crystals. Epitaxy is a process 
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whereby material of one crystal type is precipitated upon the surface of another whose lattice 
dimensions are almost identical. Epitaxy is clinically important in the formation of calcium 
oxalate stones. These two processes are closely related to heterogeneous nucleation.  
Growth  
After nucleation, crystal growth is the next major step in stone formation. Crystal growth is 
determined by the molecular size and shape of the molecule, the physical properties of the 
material, supersaturated solution level, pH and defects that may form in the crystal structure. 
Crystal growth is one of the prerequisites for particle formation. 
Aggregation  
Crystals in solution stick together and form a large particle. Aggregation of particles in 
solution is determined by a balance of forces, some with aggregating effects and some with 
disaggregating effects. Interparticle distance increases attractive force and favours particle 
aggregation. In various steps of stone formation, crystal aggregation is an important factor 
than nucleation and growth because aggregation occurs within seconds.  
Type of stones 
Calcium stone: This is most common type of calcium stones are calcium hydrogen 
phosphate dihydrate (Brushite crystals) and calcium oxalate. Calcium is a normal part of a 
healthy diet. Calcium that is not used by the bones and muscles goes to the kidneys. In most 
people, the kidneys flush out the extra calcium with the rest of the urine. For some people this 
calcium gets accumulated and aggregates with other waste products to form stones.  
Struvite stone: These stones normally develop after an infection in the urinary system. These 
stones contain the mineral magnesium and the waste product ammonia.  
Uric Acid Stone: These stones form when there is too much acid in the urine. Metabolic 
disorders that cause improper acidification of the urine mostly end in the formation of uric 
acid stones. This can be prevented by reducing the amount of meat in diet.  
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Cystine stone: Their occurrence is mostly rare. Cystine is one of the building blocks that 
make up muscles, nerves, and other parts of the body. Excessive accumulation of cystine due 
to improper dietary factors can result in cystinuria, which ultimately ends up in stone 
formation.  
Symptoms of kidney stone 
1. Extreme pain due to acutelyblocks the flow of urine 
2. Person feels a sharp, crampingpain in the back and side in the area of kidney or 
lower abdomen. 
3. Nausea and vomiting 
Diagnosis of kidney stone   
1.  X- ray or sonogram 
2. CT (computed tomography) scan or an IVP (intravenous pyelogram). 
These tests help to determine the proper treatment. 
Treatment of kidney stones  
1. Disintegrate the stone at a microscopic level.  
2. Completely flush out all dissolved particles painlessly. 
3. Prevent bacteria from collecting in the urinary tracts.  
4. Keep kidneys from forming stones again. 
MATERIALS AND METHODS [106, 107] 
Chemicals 
10Mmcalciumchloridedihydrate (CaCl2.2H2O) 
4mM sodium oxalate (Na2C2O4) 
0.15M sodium chloride 
Principle 
The effect of calcium oxalate crystallization was determined by the time course 
Chapter VII                                                                Pharmacological Studies 
Department of Pharmacognosy, MMC.      Page 86 
measurement of turbidity changes due to the crystal nucleation and aggregation in the 
calcium chloride dehydrate solution on the addition of 0.15M sodium oxalate. The 
precipitation of calcium oxalate at 37°C and pH-6.5 has been studied by the measurement of 
turbidity at 620nm. A spectrophotometer UV/Visible (Shimadzu 1800) was employed to 
measure the turbidity of the formation of calcium oxalate  
Preparation of calcium chloride and sodium oxalate solution 
0.15M Sodium chloride solution was prepared by standard procedure.10mM of 
calcium chloride dihydrate and 4mM sodium oxalate was prepared by 0.15M sodium chloride 
solution as solvent.  
Procedure 
Study without inhibitor 
 About 1.5mL of calcium chloride dihydrate was transferred in to cell and the blank 
reading was recorded. Then 1.5mL of sodium oxalate was added to above solution and the 
absorbance was recorded at 620nm within 10min of the addition of this solution. 
Study with inhibitor 
Various concentration of ethanolic extract of Andrographis  echioides was prepared 
by using 0.15M sodium chloride solution 1mL of calcium chloride dihyrate and 1mL of 
various concentration (1mg/ml, 2mg/ml, 3mg/ml) plant extract (inhibitor solution) were taken 
in the cell and the blank reading was recorded.  About 1mL of 4mM sodium oxalate was 
added to above solution and the absorbance was recorded at 620nm within 10min of the 
addition of this solution. The percentage of the inhibition was calculated by using the 
following formula - Percentage of inhibition = [1-(TI /TC)] X100; where Ti – Tutbidimetric 
slope with inhibitor and Tc – Turbidimetric slope without inhibitor. The results are presented 
in Table 18 and the photomicrographs of the crystals are presented in Fig. 29. 
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Microscopic study 
 A drop of crystallizable solution as well as a drop of mixture of inhibiting solution 
with crystallizable solution was placed on the microscopic slide and the crystals were 
observed by research microscope. The growth of crystals in different stages (t1 andt2) with and 
without plant extracts were observed research microscope. The effects of plant extracts on 
crystallization were noted and photograph of crystallization are given Fig. 30 and Table 19. 
SECTION C - IN VITRO ANTIDIABETIC ACTIVITY [108-112] 
 Diabetes mellitus is a group of metabolic diseases characterized by high blood sugar 
level that results from defects in insulin secretion or action or both. Diabetes was known even 
in ancient times which are characterized by excessive flow of urine, insatiable thirst, and 
extensive disturbances of carbohydrates, protein, and lipid metabolism. This disease was 
coined by Graeco-Roman physician Aretaeus of Cappadocia (80-130A.D) and derived from 
Greek word Diabainein-“To flow through” and Mellitus-“Honey sweet” which comes from 
Latin word by German physician Johann Peter Frank (1745-1821) in order to distinguish 
Diabetes mellitus. It is a disorder caused by the low levels of or the absence of the insulin 
hormone which is necessary to take glucose into the cells where they can be converted into 
energy or stored as glycogen for later use. The use of glucose in the body to provide energy is 
important as the Central Nervous System, the brain and spinal cord require glucose in order 
to make their energy or ATP. Hypoglycemia is the overproduction of or the hypersensitivity 
to the insulin produced. Insulin is produced in the pancreas. Without insulin, the body cannot 
maintain proper blood sugar levels.[8] 
Types of Diabetes mellitus 
There are two types of Diabetes mellitus. Type I diabetes (IDDM) is caused due to 
insulin insufficiency because autoimmune destruction of the islet β cells of pancreas. Patients 
are totally dependent on exogenous source of insulin. This type of diabetes constitutes less 
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than 10% of the diabetic population. Type II diabetes (NIDDM) is caused due to a metabolic 
derangement. Patients are unable to respond to insulin and it can be treated with dietary 
changes, exercise and medication. Type II diabetes is the more common form of diabetes 
constituting 90% of the diabetic population. A problematic aspect of type II diabetes is that it 
often begins insidiously and it is recognized when serious long-term complications occur. 
Symptoms of both type I and type II Diabetes 
 High levels of sugar in the blood 
 Unusual thirst 
 Frequent urination 
 Extreme hunger and loss of weight 
 Blurred vision 
 Nausea and vomiting 
 Extreme weakness and tiredness 
 Irritability, mood changes etc. 
The international diabetes foundation and WHO describe the dramatic increase in 
Diabetes mellitus that is occurring throughout the world today and the prevalence is a rising 
global concern. Recent statistics report that the disease had affected 347 million adult 
worldwide by the year 2008. An estimated 3.4 million people died from diabetes related 
consequences in the year 2004, and this number is projected to double between 2005 and 
2030.  The long–term un-regulation of blood glucose and lipid contributes directly to the 
serious life threatening complications of diabetes including nephropathy, retinopathy, 
neuropathy, cardiovascular disease and stroke.  
The herbal drugs with anti-diabetic activity are yet to be commercially formulated as 
modern medicines, even though they have been acclaimed for their therapeutic properties in 
the traditional systems of medicine.  The plants provide a potential source of hypoglycemic 
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IN-VITRO ANTI -DIABETIC METHODS  
The anti-diabetic activity was carried out by the following methods 
 Non-enzymatic glycosylation of Haemoglobulin assay 
 Glucose uptake by yeast cells 
 Alpha-amylase inhibition assay 
 Alpha-glycosidase inhibition assay 
METHOD 1: Non-enzymatic glycosylation of Haemoglobulin assay 108,110] 
Glycated hemoglobin (Hemoglobin A1c, A1C, or Hb1c; sometimes also HbA1c) is a 
form of haemoglobin that is measured primarily to identify the average plasma glucose 
concentration over prolonged periods of time The amount of glycated hemoglobin should not 
be more than 12%.In Diabetes mellitus, higher amounts of glycated hemoglobin, indicating 
poorer control of blood glucose levels, have been associated with cardiovascular disease, 
nephropathy, and retinopathy. Monitoring HbA1c in type 1 diabetic patients may improve 
outcome of treatment. 
Principle 
 Glycation of proteins is a frequent occurrence, but in the case of hemoglobin, a non-
enzymatic reaction occurs between glucose and the N-end of the beta chain. This forms a 
Schiff base which is itself converted to 1-deoxyfructose. This rearrangement is known as 
Amadori rearrangement. When blood glucose levels are high, glucose molecules attach to the 
hemoglobin in red blood cells. The longer hyperglycemia occurs in blood, the more glucose 
binds to hemoglobin in the red blood cells and higher the glycated hemoglobin Fig. 21. 
Glucose levels are intermittently raised in portal vessels carrying absorbed glucose to the 
liver for regulation. Passing red cells will have increased glycation after sugary food intake. 
Once a hemoglobin molecule is glycated, it remains that way. A buildup of glycated 
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absorbance was measured at 520nm by using colorimeter. The reaction mixture without 
sample was used as control. Water used as blank.  Alpha-tocopherol (Trolax) was used as 
standard. The percentage inhibition was calculated using the formula - (As-Ac)/As X 
100whereAS – Absorbance of sample and AC – Absorbance of Control. The results obtained 
are presented in Table 21 and the graphical representation is presented in Fig. 31. 
METHOD 2: Glucose uptake in Yeast cells method [109.110] 
Reagents 
10% v/v Baker’s yeast suspension 
Glucose solution (5mM,10mM) 
   Glucose oxidase solution 
Preparation of yeast suspension 
2g of commercial Baker’s yeast was mixed with distilled water and centrifuged at 
3,000rpm for 5min and the supernatant fluid was removed and again centrifuged till 
supernatant fluid was clear then 10%v/v yeast suspension was prepared by dissolving the 
yeast with distilled water. 
Procedure 
To the ethanolic extract of Andrographis echioides was dissolved in ethanol to get 
stock solution containing 1mg/mL. 1mL ofvarious concentrations of stock solution (20-
100µg/mL) of the extract was added to 1mL of 5mM, 10mM of glucose solution in separate 
tubes and then incubated at 37°C, and 100µL of 10%v/v yeast suspension was added.  It was 
vortexed and further incubated at 37°C for 1h, and then the tubes were centrifuged for 5min. 
The supernatant fluid was separated and 50µL of supernatant fluid was added to 1mL of 
glucose oxidase solution and kept aside for 20min. The absorbance of the colour developed 
was measured at 520nm by using a colorimeter. Water used as blank and the reaction mixture 
without sample used as control. Acarbose used as standard. The increase is glucose uptake 
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Reagents 
Glucose or potato starch(1% w/v in sodium acetate buffer) 
Alpha- amylase enzyme (1% w/v in sodiumacetate buffer) 
0.1M sodium acetate buffer(pH 7.2) 
 Iodine –iodide indicator 
Acarbose (1mg/mL in sodiumacetate buffer) 
Preparation of sodium acetate buffer 
820.3mg of sodium acetate and 18.7mg sodium chloride was dissolved in 100mL of 
distilled water. 
Preparation of iodine-iodide indicator 
635mg of iodine and 1g of potassium iodide was dissolved in 250mL of distilled 
water. 
Procedure 
To the ethanolic extract of Andrographis echioides was dissolved in sodium acetate 
buffer to get stock solution containing 1mg/mL.1mL of various concentrations of stock 
solution (100-1000µg/mL) of the extract was added to 1mL of 1%w/v of glucose solution, 
1mL of alpha-amylase (1%w/v) and 2mL of sodium acetate buffer(0.1M, pH 7.2) and the 
reaction mixture was incubated for 1h. 0.1mlLof iodine-iodide indicator was added. The 
absorbance was measured at 565nm of the resulting chromophore by using UV-Visible 
spectrophotometer. Sodium acetate buffer was used as blank. The reaction mixture without 
sample was used as control and acarbose used as standard. The percentage inhibition was 
calculated using the formula - Percentage inhibition of α-amylase = (As-Ac)/As X 100, 
where AS – Absorbance of sample and AC – Absorbance of control. The results are presented 
in table 23 and the graphical representation in Fig. 34. 
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Reagents 
α-glucosidase enzyme (1U/ml) 
0.2 M Tris buffer (pH -8) 
Glucose (2%w/v) 
Glucose oxidase solution 
Procedure 
To the ethanolic extract of Andrographis echioideswas dissolved in ethanol to get 
stock solution containing 1mg/mL.  1mL of various concentration of stock solution (200-
1000µg/ml) of the extract was added to 1mL of 2%w/v of glucose with 1mL of 0.2M Tris 
buffer (pH -8) and incubated for 5min at 37°C.  The reaction was initiated by adding 1mL of 
α-glucosidase enzyme (1U/mL) followed by incubation for 10min at 37°C. Then the reaction 
mixture was heated for 2min in boiling water bath to stop the reaction. The amount of 
liberated glucose is measured by glucose oxidase solution. The absorbance was measured at 
540nm by using UV-Visible spectrophotometer. Water was used as blank and the reaction 
mixture without sample was used as control. Acarbose used as standard. The percentage 
inhibition was calculated using the formula - Percentage inhibition of Alpha-glucosidase 
=(Ac-As)/Ac X 100, where AC – Absorbance of control and AS – Absorbance of sample. The 
results obtained are presented in table 24 and the graphical representation in Fig. 35. 
 
SECTION D - ANTI MICROBIAL ACTIVITY [103-118] 
 Plants produce a huge variety of secondary compounds as natural protection against 
microbial and insect attack. Some of these compounds are also toxic to animals, but others 
may not be toxic. Indeed, many of these compounds have been used in the form of whole 
plants or plant extracts for food or medical applications in man. 
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Human infections particularly those involving micro-organisms are bacteria, fungi, 
viruses, nematodes cause serious damages in tropical and subtropical countries of the world.  
In recent years, multiple drug resistance in human pathogenic microorganisms has been 
developed due to indiscriminate use of commercial antimicrobial drugs commonly used in the 
treatment of such diseases.  
The World Health Organization estimated that 80% of the populations of developing 
countries still rely on traditional medicines, mostly plant drugs for their primary health care 
needs. Herbs are supposed to be safe but many unsafe and fatal side effects have recently 
reported. Hence, there is an urgent need to study the screening of antimicrobial properties of 
herbs, which will be helpful in the treatment of several diseases caused by microorganisms. 
Many plant families represent reservoir of effective chemotherapeutics and can 
provide valuable source of natural antimicrobials. Thus for many thousands of years, plant 
extracts have been used because of their antimicrobial traits, which are due to the compounds 
synthesized in the secondary metabolism of the plant. Anti- microbial properties of plant 
components were first documented in the late 19th century. Plants have an almost limitless 
ability to synthesize aromatic substances, most of which are phenols or their oxygen 
substituted derivatives. Most of the secondary metabolites, which at least 12,000 have been 
isolated. These substances serve as plant defence mechanisms and herbivores. 
Antibacterial activity  
The ethanolic extract of Andrographis echioides was screened for antibacterial 
activity on five bacterial strains and the zone of inhibition, minimum inhibitory concentration 
was determined. 
Preparation of extract  
The ethanolic extract of Andrographis echioides was dissolved in DMSO solution and 
to produce a stock solution of 2mg/mL.  
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Preparation of MH agar medium 
Muller Hinton agar (MH, HI media) was used for culture of bacterial strains.It 
consists of Beef 2g, casein acid hydrolysate 17.5g, starch 1.5g and agar 17g (pH 7.4 ± 0.2). 
MH agar (38g) was weighed and dissolved in 1000ml of distilled water and adjusted to pH 
7.3 ± 0.2, sterilized by autoclaving at 121oC for 15min at 15psi pressure and was used for 
sensitivity tests. This medium was used for screening Staphylococcus aureus, Pseudomonas 
aeruginosa, Klebsiella spp. and Escherichia coli. 
Preparation of Blood agar medium  
Blood agar medium (BAM) contains mammalian blood usually at a concentration of 
5–10%. Blood agar medium are enriched, differential media used to isolate fussy organisms 
and detect hemolytic activity. β-hemolytic activity will show lysis and complete digestion of 
red blood cell contents surrounding colony.  
The media contains nutrient substrate (heart extract and peptones) 20.0; sodium 
chloride 5.0: agar-agar 15.0. 40g of the above media was suspended in 1000mL of distilled 
water and autoclaved for 15min at 121°C and cooled to 45-50°C. The prepared medium was 
clear and yellowish-brown and then 5-8% defibrinated blood was added.  
The blood agar medium was used for the antibacterial activity against the bacterial 
strains namely Streptococcus pyogens. 
Preparation of bacterial cultures  
 The various bacterial strains like E.coli, Klebsilla spp, Pseudomonas aeruginosa, 
Streptococcus pyogens, Staphylococcus aureus etc. were utilized for screening antibacterial 
activity. A few colonies of the bacterial strains picked from the agar slopes and were 
inoculated into 4mL peptone water in a test tube. They were incubated for 24h to form 
suspensions. The suspension was diluted with saline if necessary. 
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  The visual density equivalent to standard prepared by adding 0.5ml of 1% barium 
chloride to 99.5mL of 1%sulphuric acid. These suspensions were then used for seeding.  
Disc diffusion technique 
The MH media was poured aseptically into sterilized petridishes and the petridishes 
were swirled to settle the agar and allowed to cool .The bacterial strains were the seeded on 
the MH agar media by streaking the plate with a sterile swab containing the strain. The plain 
sterile discs were impregnated with various volumes of the extract, l and DMSO (negative 
control) and dried. Amikacin (30µg/disc) was used as standard. The discs were then placed 
on the plate with the help of sterile needle and the plates were incubated at 37°C for 24h. 
Similarly the blood agar medium was used for antibacterial activity against the 
Streptococcus species and the above procedure was adopted.  
The results were read and the zone of inhibition was then measured and they are 
presented in Tables 27.The photographic representations of the antibacterial activity are 
presented in Figs 36. 
 
Anti –fungal activity [119-122] 
Disc diffusion method 
Inoculum preparation 
The fungal colony to be tested was grown in potato dextrose agar slant at 35° C to 
induce the conidium and sporangiospore formation. After 7-10 days of incubation with well 
grown spores, the culture was taken for testing. 5ml of 0.85% sterile saline was added to the 
culture tube and the suspension were made by gently probing the colonies with the tip of 
Pasteur pipette. With the help of sterile pipettes, the saline with conidia was transferred in to 
a sterile screw cap tube. The tube was then vortexed for 30sec to 1min and allowed to stand 
at room temperature for 5 to 10min for the heavier particles to settle down. The upper 
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homogenous suspensions were collected and the densities of the conidial suspensions were 
read and adjusted the optical density (OD) to be between 0.09 and 0.11 for Aspergillus 
species, 0.15 to 0.17 for Fusarium species by using UV Visible spectrophotometer at 530nm. 
The suspensions were diluted 1:50 in RPMI 1640 medium. The final concentration of the 
conidia was 0.2 – 1 X 104 cfu/mL.  
Preparation of media 
Sabourand Dextrose Agar (Hi- media) media (SDA) was used for cultivation of fungi 
and particularly pathogenic fungi associated with skin infections. Formula gm/litre  Peptone - 
10g, dextrose 40g and agar 15 g; pH 5.6 + 0.2.  SDA (65g) was dissolved in 1000ml of 
distilled water. The medium was sterilized by autoclaving at 121oC for 15 minutes at 15 psi 
pressure. 
Preparation of extract 
A stock solution of 400mg/mL of the ethanolic extract of the plant Arographis 
echioides was prepared by dissolving the required quantity of the extract in DMSO. 10, 20 
and 30µL were impregnated on the plain sterile disc and dried.  
Procedure 
The entire dried agar surface was evenly streaked in three different directions with a 
sterile cotton swap dipped into the inoculum suspension. The plate was allowed to dry for 
20min. using a pair of flame sterilized forceps the extract containing discs were applied on to 
the surface of the inoculated plates. The plates were incubated at 35°C for 48h. The plates 
were read at 24h and 48h. Itraconazole used as standard. (30µl/mL). The results obtained are 
presented in Table 29 and Fig. 38. 
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RESULTS AND DISCUSSION 
SECTION A - IN VITRO ANTIOXIDANT ACTIVITY 
Method I: Free radical Scavenging activity using diphenylpicrylhydrazyl (DPPH) free 
radical 
The results obtained for the free radical scavenging activity against DPPH radical is 
presented inTable 13. 
Table 13: Percentage inhibition of ethanolic extract of 
Andrographis echioides and standard ascorbic acid  
against DPPH at 517nm 
 
S. No. Conc. in μg/mL 
Percentage inhibition 
by ascorbic acid 
Percentage inhibition 
by A. echoiodes 
1 40 39.36±0.03 34.3±0.01 
2 80 47.06±0.008 41.46±0.02 
3 120 70.84±0.02 55.90±0.06 
4 160 88.94±0.02 62.12±0.01 
5 200 96.47±0.01 80.33±0.06 
 IC50 84.77μg/mL 112.090μg/mL 
  *mean of three readings ± SEM 
Fig 24: Free radical scavenging assay of ascorbic acid and 
70%ethanolic extract of Andrographis echioides against DPPH at 517nm 
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 From the table 13, it can been seen that the 70%ethanolic extract of Andrographis 
echioides showed a percentage inhibition of 80.33±0.06 while ascorbic acid showed  a 
percentage inhibition of96.47±0.01 at a concentration of 200µg/mL. The IC50 value 
calculated using the linear regression analysis was found to be112.090μg/mL and 
84.77μg/mLfor70% ethanolic extract and ascorbic acid respectively. The extract possessed a 
good radical scavenging capacity 
Method 2: Determination of scavenging activity against hydrogen peroxide 
The results obtained for the scavenging activity against hydrogen peroxide are 
presented in Table 14. 
Table 14: Percentage inhibition of hydrogen peroxide of 
ascorbic acid and 70%ethanolic extract of Andrographis echioides 
 
 
 
 
 
 
 *mean of three readings ± SEM 
 From the table 14, it can be seen that the 70% ethanolic extract of Andrographis 
echioides showed a percentage inhibition of75.27±0.03 while ascorbic acid showed a 
percentage inhibitionof86.70±0.05 at a concentration of 200µg/mL. The IC50 value calculated 
using the linear regression analysis was found to be 150.086μg/mL and 115.441μg/mL for 
ethanolic extract and ascorbic acid respectively. The extract possessed a better hydrogen 
peroxide scavenging activity comparable to that of ascorbic acid. 
 
 
S. 
No. 
Conc. in 
μg/mL 
Percentage 
inhibition by 
ascorbic acid 
Percentage inhibition 
by Andrographis 
echioides 
1 50 18.2±0.20 5.89±0.02 
2 100 37.68±0.003 17.67±0.06 
3 150 72.29±0.10 52.45±0.02 
4 200 86.58±0.05 75.27±0.03 
 IC50 115.441μg/mL 150.086μg/mL 
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Fig 25: Percentage inhibition of hydrogen peroxide by 
ethanolic extract of Andrographis echioides 
 
 
Method 3: Ferric reducing anti -oxidant assay 
The results obtained for the ferric reducing antioxidant assay is presented in Table 15. 
Table 15: Ferric reducing anti-oxidant assay of ascorbic acid 
and ethanolic extract of Andrographis echioides 
 
S. 
No 
Conc. 
in 
µg/mL 
Absorbance of 
ascorbic acid 
Absorbance of 
ethanolic extract of 
A. echioides 
1 50 0.736±0.0008 0.520±0.001 
2 100 0.831±0.0008 0.610±0.003 
3 150 0.954±0.0006 0.730±0.000 
4 200 1.130 ±0.0003 1.010±0.001 
5 250 1.410 ±0.0008 1.251±0.001 
  *Mean of three readings ± SEM 
 From the table 15, it can be seen that the 70% ethanolic extract of Andrographis 
echioides showed a stoichometric increase in absorbance with increase in concentration. A 
maximum absorbance of 1.251 ± 0.001 and 1.41 ± 0.0008 was seen for the extract and 
ascorbic acid at a concentration of 250µg/mL respectively.  
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Fig.26: Ferric reducing anti-oxidant assay of 
70%ethanolic extract of Andrgraphis echioides 
 
 
Method 4: Reducing power assay  
The results obtained for the reducing powerassay is presented inTable 16. 
Table 16: Reducing power assay of ascorbic acidand 
ethanolic extract of Andrographis echioides 
 
S. 
No 
Conc. in 
µg/mL 
Absorbance of 
ascorbic acid 
Absorbance of 
ethanolic extract of A. 
echioides 
1 200 0.754±0.008 0.42±0.001 
2 400 0.825±0.001 0.62±0.001 
3 600 0.930±0.001 0.81±0.001 
4 800 0.980 ±0.003 0.89±0.001 
5 1000 1.060 ±0.005 0.91±0.001 
   *mean of three readings ± SEM 
 From the table16, it can be seen that the 70% ethanolic extract of Andrographis 
echioides showed a stoichometric increase in absorbance with increase in concentration. A 
maximum absorbance of 0.91 ± 0.001and 1.06 ± 0.005 was seen for the extract and ascorbic 
acid at a concentration of 1mg/mL respectively.  
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Fig. 27: Reducing power assay of Andrographisechioides 
 
 
 
 
 
 
 
 
 
Method 5: Total antioxidantactivity by Phosphomolybdenum Method 
The results obtained for total antioxidant activity by phosphomolybdenum is 
presented in Table 17. 
Table 17:  Total anti-oxidantassay of ascorbic acid 
and ethanolic extract of Andrographis echioides(L.)Nees 
 
S. No Conc. in µg/mL 
Absorbance of 
ascorbic acid 
Absorbance of 
ethanolic extract of 
A. echioides 
1 16 0.086±0.003 0.05±0.003 
2 33 0.170 ±0.003 0.12±0.003 
3 50 0.220 ±0.000 0.19±0.001 
4 66 0.320 ±0.001 0.29±0.001 
5 83 0.380 ±0.003 0.30±0.001 
    *mean of three readings ± SEM 
 From the table 17, it can be seen that the 70% ethanolic extract of Andrographis 
echioides showed a stoichometric increase in absorbance with increase in concentration. A 
maximum absorbance of 0.30 ± 0.001 and 0.38 ± 0.003 was seen for the extract and ascorbic 
acid at a concentration of 83µg/mL respectively.  
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Fig. 28: Total Anti-oxidant assay of ascorbic acid and ethanolic extract of 
Andrographis echioides (L.)Nees 
 
 
SECTION B - IN VITRO CALCIUM OXALATE CRYSTALLIZATION INHIBITION  
This study was designed to evaluate the inhibiting potential of ethanolic extract of 
Andrographis echioides on in vitro calcium oxalate crystallization. The concentration of 
inhibitor (EAE), turbidimetric slope relating to the curves of crystallization with and without 
inhibitor and percentage of inhibition were tabulated. The results of the percentage inhibition 
of the extract on the calcium oxalate crystallization are presented in Table 18. 
The effect of ethanolic extract of Andrographis echioides on various phases of 
calcium oxalate crystallization was determined by time course measurement of turbidity in 
the calcium chloride solution. 
In this experiment, initial detectable increase in the turbidity after induction of the 
crystallization with sodium oxalate was observed. In the control experiment, there was an 
initial steep rise in turbidity in the nucleation phase and attained maximum, followed by a 
decrease in the aggregation. 
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Table 18: Effect of 70% ethanolic extract of Andrographis echioides (L)Nees 
on calcium oxalate crystallization 
 
Conc. of 
Inhibitor in 
mg/mL 
Slope Percentage inhibition 
0 0.0432 0 
1 0.0395 14.58 
2 0.0243 43.75 
3 0.012 72.2 
 
The ethanolic extract of Andrographis echioides inhibited the slope of turbidity in a 
concentration dependent manner and followed by very slow decrease. Crystallization by the 
addition of calcium chloride and sodium oxalate was inhibited by ethanolic extract of 
Andrographis echioides at concentration of 1mg/mL, 2mg/mL; 3mg/mL inhibit calcium 
oxalate crystallization at the percentage of 14.58%, 43.75%, and 72.2% respectively. 
Microscopy study 
The photographs indicating the different stages of growth of Calcium oxalate (t1 and 
t2) with and without inhibitor were presented in Figs 29 andTable 19. 
Table 19: Time corresponding to the stage of crystallization with and without inhibitor 
Number of 
Photographs 
Stages 
ofCrystallization
Concentration 
of inhibitor Time(seconds) 
1 Growth 00 20 
2 Aggregation 00 50 
3 Growth 3mg/ml(EAE) 60 
4 Aggregation 3mg/ml(EAE) 120 
 
Identification test for calcium oxalate crystals 
1. A drop of crystallizable solution was mixed with a drop of hydrochloric acid and 
viewed under the microscope. Solublilization of crystals was observed. 
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2. A drop of acetic acid was mixed with drop of crystallizable solution and viewed 
under the microscope. No change was observed in the crystallizable solution. 
3. 50% sulphuric acid was added to the crystallizable solution, a gradual separation 
of needle like crystal of calcium oxalateat the site of original crystal. 
Crystals of calcium oxalate are primary constituent of more than 60% of the majority 
of human kidney stones. In vitro crystallization systems are used for variety of purposes in 
urolithiasis research. Since kidney stone formation is a complex process it includes super 
saturation, nucleation, growth, aggregation and retention within renal tubules. Initial events 
of nucleation of crystals occur in the first few minutes, the graphs were re-plotted within the 
first three minutes for each concentration of extract as well as control. The initial positive 
slope of the turbidity curve which is mainly due to increase in the particle number resulting 
from crystal nucleation, after a plateau is achieved in this negative slope (i.e) a progressive 
decrease of absorbance reflected from the decrease in the particle number due to the crystal 
aggregation. 
Fig. 30: Variance of absorbance according to time with inhibitor (EAE) 
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of urolithiasis found in urine include inorganic (eg. magnesium, pyrophosphate) and organic 
citrate, uro-epithelial glycoproteins, prothrombin fragment and glycosamino glycones, 
Organic compounds adsorb to the surface of crystal and inhibit the crystal nucleation, growth, 
aggregation are possible therapeutic strategy. 
The medicinal plants contain chemical compounds which possess an inhibitor effect 
in the crystallization of calcium oxalate. Calcium oxalate inhibitors prevent crystal growth 
and aggregation by coating the surface of the growing calcium crystals or by complexing 
with calcium and oxalate. Chemical constituent like higher carboxylic acid like citrate 
chelates calcium and form soluble chelates and excrete through urine. Macromolecules of 
higher weight of plant extract exert their mode of action similar to natural urinary inhibitors. 
Several studies are carried out using microscope to validate the results obtained by the 
turbidimetric method. Microscope observations revealed that the extract visibly reduces the 
size of crystals with significant reduction of crystal number.  Phenol, flavonoids, tannins were 
present in Andrographis echioides extract. Phenolic compounds have been reported for 
urolithiasis.  Hence the calcium oxalate crystallization inhibition of ethanolic extract of 
Andrographis echioides may be due to the presence of phenolic compounds present in the 
extract. 
SECTION C - IN VITRO ANTIDIABETIC ACTIVITY  
Method 1: Non enzymatic glycosylation of haemoglobin 
 The results obtained for non-enzymatic glycosylation of haemoglobin is 
presented in Table 20and the graphical representation in Fig 31. From the table 20, it can be 
seen that the 70% ethanolic extract of Andrographis echioides showed a percentage inhibition 
of 68.5±0.11 while α-tocopherol showed a percentage inhibition of 79.95±0.088 at a 
concentration of 100µg/mL. The IC50 value calculated using the linear regression analysis 
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was found to be 68.19μg/mL and 58.56μg/mL for ethanolic extract and α-tocopherol 
respectively.  
Table 20: In vitro non enzymatic glycosylation of haemoglobin 
S. 
No. 
Conc. in 
µg/mL 
α-Tocopherol Andrographisechioidesextract
Absorbance % inhibition Absorbance % inhibition 
1 20 0.159±0.0034 23.53±0.20 0.14±0.0008 16.38±0.080 
2 40 0.187±0.0029 34.60 ±0.47 0.17±0.0014 28.24±0.066 
3 60 0.258±0.0045 52.79±0.05 0.24±0.0028 49.41±0.147 
4 80 0.386±0.0041 68.57±0.45 0.31±0.0026 60.25±0.021 
5 100 0.588±0.0043 79.95±0.09 0.39±0.0008 68.50 ±0.110 
  IC50 58.56μg/mL IC50 68.19μg/mL 
*mean of three readings ± SEM 
Fig 31:In vitro non enzymatic glycosylation of haemoglobulin 
 
METHOD 2: Glucose uptake in yeast cells method 
             The results obtained inhibition of glucose (5mM & 10mM) uptake in yeast cells are 
presented in Table 21 and the graphical representation in Fig32, 33. From the Table 21, it 
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concentration of 100µg/mL.  The IC50 value calculated using the linear regression analysis 
was found to be 91.83μg/mL and113.87μg/mL respectively for ethanolic extract and 
acarbose.  
Table 21: Percentage inhibition of glucose uptake in 5mM concentration 
S. 
No. 
Conc. 
in 
µg/mL 
Acarbose Andrographisechioidesextract 
Absorbance % inhibition Absorbance % inhibition 
1 20 0.06±0.0003 35.47±0.003 0.051±0.001 20.13±0.03 
2 40 0.09±0.0003 56.03±0.003 0.070 ±0.003 42.76±0.03 
3 60 0.14±0.0003 72.56±0.030 0.100 ±0.003 60.2±0.05 
4 80 0.16±0.0005 75.73±0.030 0.143±0.003 71.36±0.03 
5 100 0.19 ±0.0003 78.66±0.033 0.150 ±0.003 73.13±0.03 
  IC50 91.83μg/mL IC50 113.87μg/mL 
                                               *mean of three readings ± SEM 
Fig. 32: Percentage inhibition of 5mM glucose uptake 
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calculated using the linear regression analysis was found to be 53.57μg/mL and 98.37μg/mL 
for ethanolic extract and acarbose respectively. 
Table 22: Percentage inhibition of glucose uptake in 10 mM concentration 
S. 
No. 
Conc. 
in 
µg/mL
Acarbose Andrographisechioides 
Extract 
Absorbance % inhibition Absorbance % inhibition 
1 20 0.129±0.001 37.95±0.023 0.10±0.003 20.13±0.03 
2 40 0.181±0.003 55.08±0.040 0.13±0.003 38.44±0.01 
3 60 0.230 ±0.001 66.13±0.033 0.15±0.003 46.70 ±0.05 
4 80 0.260 ±0.001 70.03±0.030 0.19±0.003 57.83±0.03 
5 100 0.300 ±0.001 74.13±0.033 0.23±0.005 63.57±0.04 
  IC50 98.37μg/mL IC50 53.57μg/Ml 
*Mean of three readings ± SEM 
Fig 33: Percentage inhibition of glucose uptake in 10mM concentration 
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Table 23: α-amylase inhibitory activity of acarbose and Andrographisechioidesextract 
S. 
No 
Conc.in  
µg/mL 
Acarbose 
 
Andrographis echioides extract
 
Absorbance % inhibition Absorbance % inhibition 
1 200 0.097±0.0006 43.20 ±0.057 0.083±0.0008 39.03±0.005 
2 400 0.107±0.0003 53.70 ±0.050 0.098±0.0003 48.97±0.005 
3 600 0.146±0.0003 65.76±0.008 0.110 ±0.0005 54.96±0.005 
4 800 0.188±0.0007 70.89±0.005 0.130 ±0.0006 61.83±0.005 
5 1000 0.220±0.0003 75.26±0.120 0.157±0.0005 66.60 ±0.057 
  IC50 478.80μg/mL IC50  581.95μg/Ml 
*mean of three readings ± SEM 
From the Table 23, it can be seen that the 70% ethanolic extract of Andrographis 
echioides showed a percentage inhibition of 66.6±0.057 while acarbose showed a percentage 
inhibition of 75.26±0.12 at a concentration of 1mg/mL.  The IC50 value calculated using the 
linear regression analysis was found to be 581.95μg/mL and 478.80μg/mL for ethanolic 
extract and acarbose respectively. 
Fig. 34: α-amylase inhibitory activity of acarbose and 
 Andrographis echioides extract 
 
 
0
10
20
30
40
50
60
70
80
90
100
0 200 400 600 800 1000
Pe
rc
en
ta
ge
 in
hi
bi
tio
n 
Concentration (µg/mL) 
               α-amylase inhibition method 
Acarbose
Andrographis
echioides
Chapter VII                                                                Pharmacological Studies 
Department of Pharmacognosy, MMC.      Page 114 
METHOD 4: Alpha glucosidase inhibition assay 
The results obtained inhibition of α-glucosidase is presented in table 24 and the 
graphical representation in Fig. 35. 
Table 24: α-glucosidase inhibitory activity of acarbose and Andrographis 
echioides extract 
 
S. 
No. 
Conc. 
in 
(µg/ml) 
Acarbose Andrographis echioides extract
Absorbance % inhibition Absorbance % inhibition 
1 200 0.83 ±0.001 25.74±0.07 0.98±0.002 8.43±0.24 
2 400 0.52±0.001 45.97±0.30 0.79±0.002 31.6±0.25 
3 600 0.37±0.007 64.70±0.38 0.51±0.003 51.8±0.28 
4 800 0.21±0.001 79.63±0.10 0.40±0.001 62.7 ±0.21 
5 1000 0.10±0.001 90.61±0.47 0.21±0.001 78.3±0.46 
  IC50 487.71μg/mL IC50 636.94μg/Ml 
*mean of three readings ± SEM 
              From the Table 24, it can be seen that the 70% ethanolic extract of Andrographis 
echioides showed a percentage inhibition of 78.3±0.46 while acarbose showed a percentage 
inhibition of 90.61±0.47 at a concentration of 1mg/mL.  The IC50 value calculated using the 
linear regression analysis was found to be 636.94μg/mL and 487.71μg/mL for ethanolic 
extract and acarbose respectively. 
Fig.29: α-glucosidase inhibitory activity of acarbose and Andrographis echioides extract 
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SECTION D - ANTIMICROBIAL ACTIVITY 
Antibacterial activity 
  The results obtained for susceptibility tests for extracts against various 
microorganisms are presented in Table25 and the photographs of the plates are presented in 
Fig. 36. From the table 25, it can be seen that there is growth of organism for extract at the 
concentration of 200µg/disc itself except Streptococcus pyogens and no growth of organism in 
all concentration of extract and microorganism. 
 
Table 25: Susceptibility test against microorganisms 
S. No. Name of the sample 
Conc.in 
µg/disc 
1 2 3 4 5 
1 Control - + + + + + 
2 Standard 30 - - - - - 
3 
Ethanolic extract of 
Andrographis 
echioides 
200 + + + - + 
400 - - - - - 
600 - - - - - 
Note:  (+) indicate growth (-) indicate no growth; 
1. E.coli, 2.Klebsilla spp, 3.Pseudomonas aeruginosa, 4. Streptococcus pyogens  
       5.   Staphylococcus aureus. 
 
Minimum Inhibitory Concentration (MIC) 
The minimum inhibitory concentration was defined as the lowest concentration of the 
extract that allows no more than 20% growth of microbes after incubation on agar at 37ºC for 
18-48h. The minimum inhibitory concentrations for the ethanolic extract against various 
organisms are presented in Table 26. The minimum inhibitory concentration was found to be 
less than 200µg/disc for the all organism except Streptococcus pyogens was found to be less 
than 100µg/disc. 
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Table 26: MIC of the extract against various microorganisms 
S. No. Name of the organism MIC in µg/disc 
1 Escherichia coli < 200 
2 Klebsiellaspes <200 
3 Pseudomonas aeruginosa <200 
4 Streptococcus pyogens < 100 
5 Staphylococcus aureus < 200 
 
Zones of inhibition 
The zones of inhibition obtained for various concentrations of the ethanolic extract of 
Andrographis echioides are presented in Table 27. The zones of inhibition of the extract 
were compared with that of standard drug amikacin. The pictorial representations of the same 
are presented in Fig 37.   
Table 27: Zone of inhibition against various microorganisms 
S. 
No. Name of the organism 
Zone of inhibition( in mm ) 
StandardAmikacin30 
µg/disc 
Ethanolic extract of  
Andrographis echioides 
200 400 600 
1 Escherichia coli 24.0±0.5 _ 10.0±0.0 18.0±0.0
2 Klebsiellaspp 22.0±0.0 _ 12.0±0.5 16.0±0.0
3 Pseudomonas aeruginosa 22.0±0.0 _ 12.0±0.0 18.0±0.0
4 Streptococcus pyogens 24.0±0.5 8.0±0.0 12.0±0.5 18.0±0.0
5 Staphylococcus aureus 26.0±0.0 _ 16.0±0.0 20.0±0.5
*mean of 2 readings ±SEM 
 
The zone of inhibition of ethanolic extract of Andrographis echioides at 600µg against E. coli 
,Klebsilla spp, Pseudomonas aeruginosa, Streptococcus pyogens, Staphylococcus aureus  was 18, 
16, 18,18 and 20mm respectively.  
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Fig 37: Zone of inhibition of ethanolic extract against various organisms 
 
 
 
 
 
 
 
The results showed that the extract has exhibited significant antibacterial activity against E. 
coli, Pseudomonas aeruginosa, Streptococcus pyogens and Staphylococcus aureus when compared 
to standard Amikacin. E.coli, Klebsilla spps, Pseudomonas aeruginosa are the chief causative 
organisms to produce urinary tract infection. Since the ethanolic extract of Andrographis 
echioides showed significant activity and hence could be used in the treatment of urinary tract 
infections. 
Anti fungal activity  
The results obtained for susceptibility tests for extracts against various 
microorganisms are presented in Table 28 and photograph of the plate are presented in Fig. 
38. 
Table 28: MIC of ethanolic extract of Andrographis echioides against various fungal 
isolates 
 
S. 
No. 
Name of the 
fungal isolate 
MIC of 
Itraconazole(µg/disc)
MIC of ethanolic    
extract (µg/disc) 
1. Candida albicans 30 < 100 
2. Aspergillusniger 30 < 100 
3. Aspergillusflavus 30 200-400 
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Minimum inhibitory concentration (MIC) 
The minimum inhibitory concentration was defined as the lowest concentration of the 
extract that allows no more than 20% growth of microbes after incubation on agar at 37 ̊C for 
18 to 48h. The minimum inhibitory concentration against various microorganismsis presented 
in Table 28. The minimum inhibitory concentration of ethanolic extract of Andrographis 
echioides against the fungi Candida albicans, Aspergillus niger, found to be less 
than100µg/disc while for Aspergillus flavus it was found to be 200-400µg/disc. 
Zone of inhibition  
 The zone of inhibition by antibiotic disc diffusion method of ethanolic extract of 
Andrographis echioides is presented in Table 29. The zone of inhibition of the extract was 
compared with the standard drug itraconazole. The photograph of zones of inhibition 
obtained is presented in Fig 38 and graphical representation present in Fig 39. 
Table 29: Zone of inhibition of ethanolic extract against various micro organisms 
S. 
No. 
Name of the 
organism Itraconazole
Zone of inhibition(mm)* 
Conc.of extract in mcg/disc 
200 400 600 
1 Candida albicans 24.0 ± 0.0 12.0±0.10 16.0±0.1 20.0±0.2
2 Aspergillusniger 16.0±1.0 6.0±0.02 12.0±0.0 14.0±0.0
3 Aspergillusflavus 16.0±0.0 -- 6.0±0.0 14.0±0.2
* mean of 2 readings ± SEM 
From the Table 29 the zone of inhibition of extract of Androgrphis echioides against 
various fungi tested was less than that produced by the standard drug itraconazole. The 
activity against fungi was moderately good. 
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Fig 39: Zone of inhibition of Andrographis echioides and Itraconazole 
 against various organisms 
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CHAPTER 8 
SUMMARY AND CONCLUSION 
There are many unknown plants with high medicinal value still have not recognized their 
importance. They have not been brought to the light scientific world. The pharmacopoeial 
standards in Ayurvedic Pharmacopoeia of India are not adequate enough to ensure the quality of 
plant materials since the material received in the manufacturing premises are not in a condition 
that effective microscopic examination alone will help. Recently there has been a revival of 
interest on medicinal plants. 
In the present dissertation entitled “Pharmacognostical, Phytochemical, and 
Pharmacological studies Andrographis echioides (L) Nees. (Acanthaceae)”, a commonly 
available plant has been explored for its pharmacognostic, phytochemical and pharmacological 
potential.  
The chapter on Pharmacognostical evaluation deals with various parameters  in order to 
substantiate and identify the plant for future work. This study establishes not only 
pharmacognostic and characterization of leaves but also microscopic and fluorescence analysis 
of the powder. These characteristics can be used as identification, authentication parameters of 
the plant. 
The chapter on Phytochemical evaluation deals with preliminary phytochemical 
screening which revealed the presence of phenols, flavonoids, saponins and triterpenoids in the 
plant extract.  
 The determination of total phenolic (41.47mg/g), total flavonoids (47.515mg/g), 
and total tannin content (53.2mg/g), total vitamin C content (222.76mg/g) 
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confirmed the significant concentration of these phytoconstituents in the ethanolic 
extract of Andrographis echioides. 
 The TLC analysis and HPTLC finger print profile on the ethanolic extract of 
Andrographis echioides will help us in the identification of the plant in future. 
 The determination of elemental analysis showed that the powder were free from 
heavy metals like mercury, arsenic, and cadmium and lead. Hence the 
Andrographis echioides was free from the toxic elements and safe for use. 
The chapter on Pharmacolgical evaluation deals with antioxidant activity, in vitro 
inhibition of calcium oxalate crystallization, in vitro antidiabetic activity and anti microbial 
activity.  
 The Section A of this chapter deals with the anti oxidant activity. The ethanolic extract of 
Andrgraphis echioides has exhibited radical scavenging activity by DPPH assay and 
Hydrogen peroxide method shown potent anti oxidant activity. 
 The Section B of the chapter deals with the effect of extract on inhibition of in vitro 
calcium oxalate crystallization. The extract had exhibited inhibition of invitro calcium 
oxalate crystallization at 3mg/mL. 
 The Section C of this chapter deals with in vitro anti diabetic activity. The effect of the 
extract of Andrgraphis echioides is as follows 
 Significant in-vitro Anti-diabetic activity was exhibited by70% ethanolic 
extract of Andrographis echioides in Non-enzymatic glycosylation of 
Haemoglobulin assay. The extract showed a percentage inhibition of 68.5 
± 0.11 while α-tocopherol showed a percentage inhibition of 79.95 ± 0.088 
at a concentration of 100µg/mL. 
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 In Glucose uptake by yeast cells method, the percentage inhibition of 
extract was 73.13 ± 0.03 while acarbose showed a percentage inhibition of 
78.66 ± 0.033 at a concentration of 100µg/mL at 5mM glucose 
concentration.  
 In Alpha-amylase inhibition assay, the extract showed a percentage 
inhibition of 66.6 ± 0.057 while acarbose showed a percentage inhibition of 
75.26 ± 0.12 at a concentration of 1000µg/mL. 
 In Alpha-glucosidase inhibition assay, the extract showed apercentage 
inhibition of  78.3± 0.46 while acarbose showed a percentage inhibition of 
90.61 ± 0.47 at a concentration of 1000µg/mL. 
 It can be concluded from the above that the extract of Andrographis echioides possess 
potent anti-diabetic activity.   
 The Section D of this chapter deals with antimicrobial activity of the extract. A 
significant anti-bacterial activity was exhibited by ethanolic extract (400µg/disc, 
600µg/disc) against Escherichia coli, Klebsella spp, Pseudomonas aeruginosa, 
Streptococcus pyogens and Staphylococcu saureus. The extract also showed significant 
anti- fungal activity (400µg/disc, 600µg/disc) against Candida albicans, Aspergillus 
niger and Aspergillus flavus. 
The ethanolic extract of Andrographis echioides may serve as a lead medicinal plant to 
synthesize various semi-synthetic drugs to treat various life threatening disease like Diabetes 
mellitus, Kidney stone, bacterial and fungal infections.  
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